Free AccessResearch Article

Tools

Facebook
Twitter
Linked In
Mendeley
Reddit

Free AccessResearch Article

Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

The Framingham Heart Study

Ramachandran S. Vasan

From the Framingham Heart Study (R.S.V., L.S., R.B.D., E.J.B., D.L., P.W.F.W.), Framingham, Mass; Cardiology Section (R.S.V., E.J.B., D.B.S.), Myocardial Biology Unit (D.B.S.), Endocrinology Section (P.W.F.W.), Preventive Medicine and Epidemiology (R.S.V., E.J.B., D.L., P.W.F.W.), Department of Medicine, Boston University School of Medicine, Boston, Mass; the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging (R.R.) at Tufts University, Boston, Mass; the Department of Medicine, University of Colorado Health Sciences Center, Denver (C.A.D.); Geriatric Epidemiology Section, Laboratory of Epidemiology, Demography, and Biometry (T.H.), National Institute on Aging, Bethesda, Md; the National Heart, Lung, and Blood Institute (D.L.), Bethesda, Md; and the Departments of Mathematics/Statistics and Biostatistics (L.S., R.B.D.), Boston University, Boston, Mass.

Search for more papers by this author

Lisa M. Sullivan

Lisa M. Sullivan

Search for more papers by this author

Ronenn Roubenoff

Ronenn Roubenoff

Search for more papers by this author

Charles A. Dinarello

Charles A. Dinarello

Search for more papers by this author

Tamara Harris

Tamara Harris

Search for more papers by this author

Emelia J. Benjamin

Emelia J. Benjamin

Search for more papers by this author

Douglas B. Sawyer

Douglas B. Sawyer

Search for more papers by this author

Daniel Levy

Daniel Levy

Search for more papers by this author

Peter W.F. Wilson

Peter W.F. Wilson

Search for more papers by this author

and

Ralph B. D’Agostino

Ralph B. D’Agostino

Search for more papers by this author

Originally published10 Mar 2003https://doi.org/10.1161/01.CIR.0000057810.48709.F6Circulation. 2003;107:1486–1491

Other version(s) of this article
- You are viewing the most recent version of this article. Previous versions:
  - March 10, 2003: Previous Version 1

Abstract

Background— Experimental studies support a key role for cytokines in left ventricular remodeling. In congestive heart failure (CHF) patients, elevated plasma cytokine levels are associated with worse functional status and adverse prognosis. It is unclear whether cytokine levels can predict the incidence of CHF in asymptomatic individuals.

Methods and Results— We investigated the relations of serum interleukin-6 (IL-6), C-reactive protein (CRP), and spontaneous production of tumor necrosis factor-α (TNFα) by peripheral blood mononuclear cell (PBMC) to CHF incidence among 732 elderly Framingham Study subjects (mean age 78 years, 67% women) free of prior myocardial infarction and CHF. On follow-up (mean 5.2 years), 56 subjects (35 women) developed CHF. After adjustment for established risk factors, including the occurrence of myocardial infarction on follow-up, there was a 60 (PBMC TNFα) to 68% (serum IL-6) increase in risk of CHF per tertile increment in cytokine concentration (P=0.04, and 0.03, respectively, for trend). A serum CRP level ≥5 mg/dL was associated with a 2.8-fold increased risk of CHF (P=0.02). Subjects with elevated levels of all 3 biomarkers (serum IL-6 and PBMC TNFα >median values, CRP≥5 mg/dL) had a markedly increased risk of CHF (hazards ratio 4.07 [95% CI 1.34 to 12.37], P=0.01) compared with the other subjects.

Conclusions— In our elderly, community-based sample, a single determination of serum inflammatory markers, particularly elevated IL-6, was associated with increased risk of CHF in people without prior myocardial infarction. Additional epidemiological investigations are warranted to confirm the contribution of inflammation to the pathogenesis of CHF in the general population.

Several clinical studies have suggested that serum levels of tumor necrosis factor-α (TNFα), interleukin-6 (IL-6), and C-reactive protein (CRP) are elevated in patients with congestive heart failure (CHF) regardless of the etiology of the condition.^1–5 Furthermore, elevated blood levels of these inflammatory markers correlate with worsening functional class, increased hospitalization rates, and poorer survival.^6–9

See p 1460

Experimental studies indicate that proinflammatory cytokines (TNFα and IL-6) are associated with certain molecular, clinical, and physiological aspects of heart failure, including but not limited to progressive left ventricular (LV) dysfunction, pulmonary edema, LV remodeling, fetal gene expression, myocyte hypertrophy, and myocyte apoptosis.¹⁰ Experimental evidence suggests that myocardial infiltration by peripheral blood mononuclear cells (PBMC) contributes to LV remodeling.^11,12 PBMC production capacity of cytokines is enhanced in CHF,^13,14 and may be related to an increased expression of genes for the TNFα superfamily.¹⁵

Thus, it is currently believed that proinflammatory cytokines may represent a class of biological mediators that are activated in CHF, akin to but distinct from neurohormones and the natriuretic peptide pathways. It is unclear whether elevated levels of inflammatory markers antedate the development of CHF. We hypothesized that individuals with increased serum levels of proinflammatory cytokines and/or with elevated PBMC production of TNFα would be at increased risk of developing CHF. Accordingly, we examined prospectively the relations of serum IL-6, CRP, and PBMC production of TNFα obtained at a routine examination to the incidence of CHF on follow-up in a community-based sample.

Methods

Study Sample

The design and selection criteria of the Framingham Heart Study have been described previously.¹⁶ Participants who attended the 22nd biennial examination cycle (1992 to 1994) were eligible for the present investigation because blood specimens for cytokine analyses were obtained at this examination. Of 1167 subjects alive at the time of the baseline examination, we excluded 435 individuals (37.3%) for the following reasons: off-site examination (n=226), prevalent CHF (n=56) or myocardial infarction (MI, n=79), and insufficient blood specimen for cytokine analyses (n=74). Subjects with an MI were excluded because plasma cytokines may be elevated for a variable duration after myocardial injury.¹⁷ Further, prior MI is a powerful trigger for cytokine activation, progressive LV remodeling, and CHF.^11,18 After exclusions, 732 participants remained eligible.

At the baseline examination, participants underwent a medical history, a physical examination, and assessment of cardiovascular disease risk factors.

Measurement of Cytokines and CRP

At the baseline examination, attendees underwent phlebotomy in the early afternoon. Specimens were immediately transported via courier from Framingham to the USDA Human Nutrition Research Center on Aging in Boston, where PBMC were isolated and cultured, and serum stored at −80°C.¹⁹ Serum IL-6 was measured with an ELISA (R&D Systems). CRP was measured with an immunoprecipitation assay (IncStar).

Although PBMC production of several cytokines was evaluated,²¹ we specified TNFα as the PBMC cytokine of interest a priori for the present investigation. Briefly, PBMC were separated by Ficoll-Hypaque centrifugation, washed, and cultured for 24 hours in 96-well flat-bottom plates with ultrafiltered,²⁰ pyrogen-free RPMI 1640 medium (Sigma) that was supplemented with 100-μg/mL streptomycin and 100-U/mL penicillin, with 1% autologous heat-inactivated pooled serum and 1% l-glutamine. After incubation, plates were then frozen at −80°C until assay. The average time from phlebotomy to isolation of PBMC was 75 minutes (range 35 to 120 minutes). Total PBMC production of TNFα was measured in unstimulated cells (spontaneous production) as well as after stimulation with 1 or 100 ng/mL of lipopolysaccharide (E. coli LPS, Sigma), as previously described.¹⁹ The interassay variability was <10%, and the intra-assay variability was <5% for all three inflammatory markers.¹⁹

Outcome

All study subjects were under continuous surveillance for the development of cardiovascular disease events. A panel of three investigators reviewed all suspected cardiovascular disease events by examining hospital records, information from physicians, and pathology reports as described previously.²¹ In the present investigation, the primary outcome of interest was the first occurrence of CHF as defined by the Framingham Heart Study criteria.²² These criteria require the simultaneous presence of at least two major criteria, or one major criterion in conjunction with two minor criteria, to establish a diagnosis of CHF, and have been validated previously.²³

Statistical Methods

We used separate multivariable Cox proportional hazards regression models²⁴ to examine the association of each inflammatory marker with the incidence of CHF. Because there was no effect modification by gender, sex-pooled analyses were performed. The inflammatory markers were analyzed both as continuous (natural logarithmic-transformed IL-6 and TNFα) and as categorical variables (tertiles for IL-6 and TNFα). In the case of CRP, we chose 5 mg/L as a cut point for dichotomizing subjects a priori because 68% of subjects had undetectable levels (because of a low-sensitivity assay), and this threshold has been reported to be of prognostic significance.^25,26

We adjusted for the following baseline covariates²¹: age, sex, ratio of serum total cholesterol to HDL cholesterol, diabetes, systolic and diastolic blood pressure, antihypertensive treatment, smoking status, body mass index (BMI), valve disease, atrial fibrillation, prevalent cardiovascular disease (other than MI), and electrocardiographic LV hypertrophy.

We examined the following multivariable models: model A, all covariates defined at baseline and ignoring the occurrence of MI on follow-up; model B, adjusting for covariates at baseline, and additionally for the occurrence of an MI on follow-up as a time-dependent covariate. The latter adjustment is important because elevated plasma cytokines can predispose to CHF by promoting MI.^27,28 Models using serum IL-6 and PBMC TNFα categories examined trends across the tertiles and compared risk of CHF in each of the two upper tertiles with the first tertile serving as a referent.

Ancillary Analyses

We examined regression models with stepwise backward elimination of the 3 inflammatory markers to investigate which of the markers remained in a model that incorporated established CHF risk factors. We also evaluated the prognostic significance of combinations of the 3 biomarkers by comparing CHF risk in individuals with “elevated” levels of all 3 markers (empirically defined as values above the median for serum IL-6 and PBMC TNFα, and ≥5 mg/dL for serum CRP) with that in the rest of the subjects.

We performed analyses incorporating several interaction terms (inflammatory markers × covariate in Model B) to examine for any variation in the effect of inflammatory markers on CHF risk (effect modification) according to age, sex, systolic blood pressure, and BMI. We performed supplementary analyses in which we modeled death as a competing outcome to CHF, given the elderly study sample. For primary analyses, we defined a priori spontaneous production of TNFα by PBMC as the variable of interest. However, we performed supplementary analyses in which levels of TNFα produced by stimulated PBMC (with 1 and 100 ng/mL of lipopolysaccharide) were related to the risk of CHF. A two-sided P value of 0.05 was considered significant.

Results

Clinical Characteristics

In our elderly sample, about 70% of subjects were hypertensive (Table 1). Serum IL-6 levels were modestly related to CRP levels in both sexes and to spontaneous PBMC production of TNFα in women (Table 2). CRP was not related to TNFα in either sex. Nine percent of the subjects had CRP levels ≥5 mg/dL.

**TABLE 1. Characteristics of Study Subjects**
Variable	Men (n=244)	Women (n=488)
Values are expressed as mean±SD or percentages.
*Systolic murmur of grade 3 or more (out of 6) or any diastolic murmur.
†Voltage criteria plus repolarization abnormalities.
‡Does not include recognized myocardial infarction, but does include angina and cerebrovascular or peripheral vascular disease. Hypertension was defined as a systolic BP ≥140 mm Hg, a diastolic BP ≥90 mm Hg, or use of antihypertensive agents.
Age, y	78.0±4.3	78.6±4.6
BMI, kg/m²	27.0±3.9	26.7±5.1
Systolic blood pressure, mm Hg	144±21	143±20
Diastolic blood pressure, mm Hg	74±11	72±11
Hypertension, %	68.4	73.6
Hypertension treatment, %	42.9	50.0
Total cholesterol, mg/dL	194±31	214±36
HDL, mg/dL	42.8±14.0	54.0±16.0
Total cholesterol/HDL	4.9±1.5	4.3±1.4
Diabetes, %	16.8	8.6
Smoking, %	6.6	9.8
Clinical valve disease, %^*	7.8	5.3
ECG left ventricular hypertrophy, %^†	3.4	3.0
Prevalent atrial fibrillation, %	10.3	5.1
Prevalent cardiovascular disease, %^‡	28.3	22.1
Myocardial infarction on follow-up, %	8.6	4.3

**TABLE 2. Mean Values and Spearman Rank Correlations Among Inflammatory Markers**
	Women			Men
	CRP, mg/L	IL-6, pg/mL	TNFα, ng/mL	CRP, mg/L	IL-6, pg/mL	TNFα, ng/mL
Values of CRP and IL-6 indicate serum levels, whereas TNFα levels refer to spontaneous production by PBMC.
*Spearman rank correlations.
†P<0.001.
Mean	1.60	6.69	4.68	2.66	7.68	5.33
SD	3.93	15.90	3.66	8.47	17.22	4.34
CRP^*	1.00	0.21^†	0.06	1.00	0.29^†	−0.06
IL-6^*	…	1.00	0.21^†	…	1.00	−0.10
TNFα^*	…	…	1.00	…	…	1.00

Inflammatory Markers and CHF Risk

On follow-up (mean 5.2 years), 56 participants (35 women) developed CHF. The cumulative incidence of CHF was greater with increasing levels of the inflammatory markers (Figure 1, Panels A-C).

Panel A, Kaplan-Meier plots showing the crude cumulative incidence of CHF in subjects according to tertiles of serum IL-6. Panel B, spontaneous production of TNF-α by PBMC, and Panel C, for individuals with serum CRP values above and below 5 mg/dL. T1, T2, and T3 represent the tertiles of the marker (T3 being the top tertile). No. of CHF cases/No. at risk for each tertile: Serum IL-6 (pg/mL); T1=7/220 (3.2%); T2=11/167 (6.6%); T3 =24/165 (14.5%). PBMC spontaneous production of TNF-α (ng/mL): T1=9/217 (4.1%); T2=18/220 (8.2%); T3=19/199 (9.5%). For serum CRP: <5 mg/dL, 48/657 (7.3%); ≥5 mg/dL, 8/66 (12.1%).

Table 3 displays the results of multivariable analyses examining the relations of serum IL-6 and PBMC spontaneous production of TNFα to the risk of CHF. There was a 36% (IL-6) to 46% (TNFα) increase in CHF risk for every standard deviation increment in log cytokine concentration (Table 3, model B1). Risk of CHF increased about 1.6-fold per tertile increment in cytokine level (Table 3, model B2).

**TABLE 3. Serum IL-6, Spontaneous Production of TNFα by PBMC, and Risk of CHF**
Model	Serum IL-6		Spontaneous Production of TNFα by PBMC
Model	HR (95% CI)	P	HR (95% CI)	P
HR indicates hazards ratio per 1 SD increment of marker. For log IL-6, 1 SD=0.64; for log TNFα, 1 SD=0.81.
*All models adjust for age, sex, diabetes, systolic blood pressure, hypertension treatment, smoking status, BMI, total cholesterol/HDL, valve disease, prevalent atrial fibrillation, prevalent cardiovascular disease (other than myocardial infarction), and ECG-LVH.
†Marker tertiles: for serum IL-6 (pg/ml), T1=<3.12, T2=3.13 to 5.27, and T3=5.28 to 275; for PBMC spontaneous production of TNFα (ng/ml): T1=0.04 to 2.60, T2=2.61 to 5.00, and T3=5.01 to 40.
A: Multivariable models adjusting for covariates at baseline^*
A1: Log marker as continuous variable	1.36 (1.09 to 1.71)	0.01	1.30 (0.91 to 1.87)	0.15
A2: Tertiles of marker^†
T1	Referent	…	Referent	…
T2	1.62 (0.57 to 4.56)	0.37	1.67 (0.68 to 4.11)	0.27
T3	3.07 (1.26 to 7.47)	0.01	2.14 (0.86 to 5.32)	0.10
Trend across tertiles	1.77 (1.15 to 2.74)	0.01	1.43 (0.93- to 2.20)	0.10
B: Models adjusting for covariates at baseline^* and for myocardial infarction on follow-up (time-dependent covariate)
B1: Log marker as continuous variable	1.36 (1.06 to 1.74)	0.02	1.46 (1.00 to 2.15)	0.05
B2: Tertiles of marker^†
T1	Referent	…	Referent	…
T2	1.77 (0.59 to 5.33)	0.31	1.91 (0.73 to 4.96)	0.19
T3	2.85 (1.09 to 7.44)	0.03	2.70 (1.02 to 7.15)	0.05
Trend across tertiles	1.68 (1.05 to 2.67)	0.03	1.60 (1.01 to 2.53)	0.04

Participants with serum CRP levels ≥5 mg/dL experienced an increased risk of CHF (model A: hazards ratio 2.18 [95% CI 1.00 to 4.79, P=0.05]; model B: 2.81 [95% CI 1.22 to 6.50, P=0.02]).

Additional Analyses

In stepwise backward elimination models, only IL-6 remained in the models after adjustment for the established CHF risk factors; the other two inflammatory markers did not.

In our sample, 11.5% of women and 7% of men had elevated levels of all three markers (elevation defined as above the median for serum IL-6 [3.52 pg/mL] and PBMC spontaneous production of TNFα [3.80 ng/mL] and CRP≥5 mg/dL). However, this group accounted for 21% of all CHF cases. Individuals with elevated levels of all 3 markers had a markedly increased risk of CHF (model A: hazards ratio 3.00 [95% CI 1.13 to 7.95, P=0.03]; model B: 4.07 [95% CI 1.34 to 12.37, P=0.01]). In stepwise models directly comparing the prognostic utility of elevation of all 3 markers with that of an increase in serum IL-6 alone, elevated serum IL-6 entered the model first; elevation of the other two cytokines did not enter the model subsequently.

The impact of the inflammatory markers on CHF risk did not vary with age, sex, systolic blood pressure or BMI (probability value for all interactions exceeded 0.10). In additional analyses with death modeled as a competing outcome to CHF, the association between IL-6 and risk of CHF remained robust. In secondary analyses, PBMC production of TNFα stimulated by LPS was not related to risk of CHF.

Discussion

For many centuries, physicians have recognized that patients with CHF may have clinical features observed in chronic inflammatory conditions.²⁹ More recently, there has been a resurgence of interest in the inflammatory origins of CHF because of the role of proinflammatory cytokines in mediating the cachexia of severe CHF.³⁰ The role of inflammation in the pathogenesis of CHF has been strengthened further, with the implication of several cytokines (notably IL-6) in the disease process in experimental studies,¹⁰ and the demonstration that inflammatory markers are elevated in patients with milder degrees of CHF,^1,2 including those with asymptomatic LV systolic dysfunction.³¹

These observations raise the possibility that levels of inflammatory markers may be elevated early in the course of LV dysfunction and could predict occurrence of subsequent CHF. The present investigation examined this hypothesis prospectively. We chose to evaluate individuals without baseline MI because the demonstration of any effect in this group would support the hypothesis that inflammatory markers promote LV remodeling and CHF even in the absence of clinically apparent preexisting myocardial injury. We chose three markers: serum IL-6, produced by diverse cells and a correlate of systemic inflammation; spontaneous production of TNFα by PBMC, indicative of in vivo responses of a population of cells that infiltrate the myocardium during LV remodeling; and serum CRP, an acute phase reactant produced by the hepatocytes.

Principal Findings

Serum IL-6 was associated with an increased risk of CHF in a continuous fashion without evidence of a threshold. Subjects with elevated CRP levels also had increased risk of CHF. The association of inflammatory markers with CHF risk was maintained on adjusting for the occurrence of an MI on follow-up. An association of increased spontaneous PBMC production of TNFα and CHF risk was also noted. Stepwise regression models identified serum IL-6 as the best predictor of CHF risk of the three markers evaluated. It is important to point out that the present investigation does not provide an adequate comparison of the relative predictive powers of IL-6 versus CRP because we used a low-sensitivity assay for the latter.

Mechanisms

The observed association between inflammatory markers and CHF risk should not necessarily be interpreted as indicating a role for IL-6 and TNFα in the pathogenesis of heart failure. It is possible that elevated serum cytokine levels are simply indicative of a generalized inflammatory state antedating CHF. Elevation of markers may be a reaction to the pathophysiological processes driving progressive ventricular remodeling.

It is also possible, however, that the association between inflammatory markers and CHF is a causal one. The strength of the association (about 60% increased risk per tertile increment), the presence of a stepwise rise in CHF risk across increasing tertiles of the markers, the demonstration of a temporal sequence, and the consistency of results in multiple analyses and across markers all support this notion. Both IL-6 and TNFα can adversely affect myocyte contractility³² and can directly influence LV remodeling,^33,34 an observation further confirmed by findings of LV dilatation and LV hypertrophy, respectively, in experiments on transgenic mice overexpressing TNFα³⁵ or IL-6 and its receptor.³⁶ The role of IL-6 in particular may be complex, as it has both proinflammatory and anti-inflammatory effects³⁷ and can both promote myocyte hypertrophy as well as protect cardiomyocytes from apoptosis.³⁸ Although elevated CRP has not been related directly to LV remodeling, it is likely that it reflects increased hepatic synthesis under the influence of elevated IL-6 levels. Conversely, CRP may promote LV remodeling by stimulating IL-6 production.³⁹

Interestingly, although spontaneous production of TNFα by PBMC was related to CHF risk, levels obtained under stimulated conditions were not. It can be argued that unstimulated cells reflect in vivo conditions better, whereas ex-vivo assessment of stimulated cells represents their maximal response to stress.¹⁹

Strengths and Limitations

The strengths of our investigation include the community-based sample and the measurement of inflammatory markers blinded to clinical outcome. Nonetheless, it is important to acknowledge the limitations of our investigation. Echocardiographic evaluation was not performed at the baseline examination, and consequently we were unable to examine the relative contributions of subclinical LV dysfunction and inflammatory cytokines to CHF risk. The use of a low-sensitivity CRP assay and the exclusion of institutionalized individuals (who were likely sicker and more likely to have elevated cytokine levels) are additional limitations. Our study sample was almost exclusively white and elderly, reducing the generalizability of our results.

Conclusions

Our findings suggest that elevated inflammatory markers constitute important risk factors for CHF in elderly women and men. Although prior reports have emphasized the importance of inflammation in determining prognosis of people with established CHF, our data suggest that the contribution of inflammatory markers may antedate overt CHF. If confirmed, our observational data raises the possibility of using inflammatory markers to identify patients at high risk for CHF. They also suggest a possible role of anti-inflammatory therapy as an experimental means to reduce risk in patients at high risk for CHF.

This work was supported through NHLBI Contract N01-HC-25195; K24 HL04334 (RSV); NIH/USDA Interagency agreement Y01-AG-4-0245 (RR); and NIH grants DK02120 (RR), AG15797 (RR), and AI-15614 (CAD).

Footnotes

Correspondence to Ramachandran S. Vasan, MD, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702-5803. E-mail [email protected]

References

1 Munger MA, Johnson B, Amber IJ, et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1996; 77: 723–727.Crossref Medline Google Scholar
2 Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996; 27: 1201–1206.Crossref Medline Google Scholar
3 Werdan K. The activated immune system in congestive heart failure-from dropsy to the cytokine paradigm. J Intern Med. 1998; 243: 87–92.Crossref Medline Google Scholar
4 Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999; 83: 376–382.Crossref Medline Google Scholar
5 Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996; 28: 964–971.Crossref Medline Google Scholar
6 MacGowan GA, Mann DL, Kormos RL, et al. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 1997; 79: 1128–1131.Crossref Medline Google Scholar
7 Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, et al. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail. 2002; 4: 331–336.Crossref Medline Google Scholar
8 Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 2000; 36: 1587–1593.Crossref Medline Google Scholar
9 Kell R, Haunstetter A, Dengler TJ, et al. Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. Eur Heart J. 2002; 23: 70–78.Crossref Medline Google Scholar
10 Baumgarten G, Knuefermann P, Mann DL. Cytokines as emerging targets in the treatment of heart failure. Trends in Cardiovasc Med. 2000; 10: 216–223.Crossref Medline Google Scholar
11 Maekawa Y, Anzai T, Yoshikawa T, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol. 2002; 39: 241–246.Crossref Medline Google Scholar
12 Shioi T, Matsumori A, Kihara Y, et al. Increased expression of interleukin-1⁻ and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res. 1997; 81: 664–671.Crossref Medline Google Scholar
13 Vonhof S, Brost B, Stille-Siegener M, et al. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol. 1998; 63: 237–244.Crossref Medline Google Scholar
14 Zhao SP, Xu TD. Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure. Int J Cardiol. 1999; 71: 257–261.Crossref Medline Google Scholar
15 Yndestad A, Kristian Damas J, Geir Eiken H, et al. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovas Res. 2002; 54: 175–182.Crossref Medline Google Scholar
16 Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: the Framingham Study. Am J Public Health. 1951; 41: 279–286.Crossref Google Scholar
17 Pudil R, Pidrman V, Krejsek J, et al. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clin Chim Acta. 1999; 280: 127–134.Crossref Medline Google Scholar
18 Sia YT, Parker TG, Liu P, et al. Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression. J Am Coll Cardiol. 2002; 39: 148–156.Crossref Medline Google Scholar
19 Roubenoff R, Harris TB, Abad LW, et al. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci. 1998; 53: M20–M26.Crossref Medline Google Scholar
20 Schindler R, Dinarello CA. Ultrafiltration to remove endotoxins and other cytokine-inducing materials from tissue culture media and parenteral fluids. Biotechniques. 1990; 8: 408–413.Medline Google Scholar
21 Kannel WB, Wolf PA, Garrison RJ, eds. Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements. Framingham Heart Study, 30-year follow-up. Bethesda, Md: US Department of Health and Human Services, 1987.Google Scholar
22 McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285: 1441–1446.Crossref Medline Google Scholar
23 Mosterd A, Deckers JW, Hoes AW, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol. 1997; 13: 491–502.Crossref Medline Google Scholar
24 Cox DR, Oakes D. Analysis of Survival Data. London, England: Chapman & Hall, 1984.Google Scholar
25 Gussekloo J, Schaap MC, Frolich M, et al. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol. 2000; 20: 1047–1051.Crossref Medline Google Scholar
26 Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000; 20: 1057–1060.Crossref Medline Google Scholar
27 Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000; 101: 2149–2153.Crossref Medline Google Scholar
28 Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000; 101: 1767–1772.Crossref Medline Google Scholar
29 Katz AM, Katz PB. Diseases of the heart in works of Hippocrates. Br Heart J. 1962; 24: 257–264.Crossref Medline Google Scholar
30 Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990; 323: 236–241.Crossref Medline Google Scholar
31 Raymond RJ, Dehmer GJ, Theoharides TC, et al. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J. 2001; 141: 435–438.Crossref Medline Google Scholar
32 Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation. 1997; 95: 778–781.Crossref Medline Google Scholar
33 Bozkurt B, Kribbs SB, Clubb FJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998; 97: 1382–1391.Crossref Medline Google Scholar
34 Bradham WS, Moe G, Wendt KA, et al. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart Circ Physiol. 2002; 282: H1288–H1295.Crossref Medline Google Scholar
35 Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation. 1998; 97: 1375–1381.Crossref Medline Google Scholar
36 Hirota H, Yoshida K, Kishimoto T, et al. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995; 92: 4862–4866.Crossref Medline Google Scholar
37 Mann DL. Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses. J Mol Cell Cardiol. 2001; 33: 1551–1553.Crossref Medline Google Scholar
38 Wollert KC, Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev. 2001; 6: 95–103.Crossref Medline Google Scholar
39 Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002; 105: 1890–1896.Link Google Scholar

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Cited By

Jia X, Buckley L, Sun C, Al Rifai M, Yu B, Nambi V, Virani S, Selvin E, Matsushita K, Hoogeveen R, Coresh J, Shah A and Ballantyne C (2023) Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study, European Journal of Preventive Cardiology, 10.1093/eurjpc/zwad197, 30:16, (1731-1740), Online publication date: 9-Nov-2023.

Müller F, Aherrahrou Z, Grasshoff H, Heidorn M, Humrich J, Johanson L, Aherrahrou R, Reinberger T, Schulz A, ten Cate V, Robles A, Koeck T, Rapp S, Lange T, Brachaczek L, Luebber F, Erdmann J, Heidecke H, Schulze-Forster K, Dechend R, Lackner K, Pfeiffer N, Ghaemi Kerahrodi J, Tüscher O, Schwarting A, Strauch K, Münzel T, Prochaska J, Riemekasten G and Wild P (2023) Autoantibodies against the chemokine receptor 3 predict cardiovascular risk, European Heart Journal, 10.1093/eurheartj/ehad666

Li S, Xie X, Zeng X, Wang S and Lan J (2023) Association between serum albumin to serum creatinine ratio and mortality risk in patients with heart failure, Clinical and Translational Science, 10.1111/cts.13636, 16:11, (2345-2355), Online publication date: 1-Nov-2023.

Tasha T, Desai A, Bajgain A, Ali A, Dutta C, Pasha K, Paul S, Abbas M, Nassar S and Mohammed L A Literature Review on the Coexisting Chronic Obstructive Pulmonary Disease and Heart Failure, Cureus, 10.7759/cureus.47895

Mangner N, Winzer E, Linke A and Adams V (2023) Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2023.1149065, 10

Saleh D, Jones R, Schroth S, Thorp E and Feinstein M (2023) Emerging Roles for Dendritic Cells in Heart Failure, Biomolecules, 10.3390/biom13101535, 13:10, (1535)

Li S, Xie X, Zeng X, Wang S and Lan J (2023) Serum apolipoprotein B to apolipoprotein A‐I ratio predicts mortality in patients with heart failure, ESC Heart Failure, 10.1002/ehf2.14547

Daou D, Gillette T and Hill J (2023) Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction, Physiology, 10.1152/physiol.00004.2023, 38:5, (217-230), Online publication date: 1-Sep-2023.

Maiello M, Cecere A, Ciccone M and Palmiero P (2023) Early diagnosis of subclinical left ventricular dysfunction in postmenopausal women with rheumatoid arthritis, Clinical Physiology and Functional Imaging, 10.1111/cpf.12822, 43:5, (313-317), Online publication date: 1-Sep-2023.

Vyas A, Desai R, Went T, Wiltshire D, Priyadarshni S, Shalaby M and Khalife W (2023) Cardiovascular Disease Burden and Major Adverse Cardiac Events in Young Black Patients: A National Analysis of 2 Cohorts 10 Years Apart (2017 Versus 2007), Journal of the American Heart Association, 12:15, Online publication date: 1-Aug-2023.

Burger P, Koudstaal S, Mosterd A, Fiolet A, Teraa M, van der Meer M, Cramer M, Visseren F, Ridker P, Dorresteijn J, Cramer M, van der Meer M, Nathoe H, de Borst G, Bots M, Emmelot-Vonk M, de Jong P, Lely A, van der Kaaij N, Kappelle L, Ruigrok Y, Verhaar M, Visseren F and Dorresteijn J (2023) C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2023.05.035, 82:5, (414-426), Online publication date: 1-Aug-2023.

Liu Y, Guan S, Xu H, Zhang N, Huang M and Liu Z (2023) Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2023.1175174, 10

KAPICI Y, ABUŞ S, AYHAN S, TİBİLLİ H and AKÇAY A (2023) Comparison of Platelet Parameters and Electrocardiogram Data in Patients with Generalized Anxiety Disorder with Healthy Control Group Yaygın Anksiyete Bozukluğu Olan Hastaların Trombosit Parametreleri ve Elektrokardiyogram Verilerinin Sağlıklı Kontrol Grubu ile Karşılaştırılması, Medical Records, 10.37990/medr.1173121, 5:2, (228-30)

Chhor M, Law W, Pavlovic M, Aksentijevic D, McGrath K and McClements L (2023) Diagnostic and prognostic biomarkers reflective of cardiac remodelling in diabetes mellitus: A scoping review, Diabetic Medicine, 10.1111/dme.15064, 40:5, Online publication date: 1-May-2023.

Fan M, Zhang J, Zeng L, Wang D, Chen J, Xi X, Long J, Huang J and Li X (2023) Non-coding RNA mediates endoplasmic reticulum stress-induced apoptosis in heart disease, Heliyon, 10.1016/j.heliyon.2023.e16246, 9:5, (e16246), Online publication date: 1-May-2023.

Habibi D, Daneshpour M, Asgarian S, Kohansal K, Hadaegh F, Mansourian M and Akbarzadeh M (2023) Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study, BMC Cardiovascular Disorders, 10.1186/s12872-023-03149-3, 23:1

GUAN B, CHEN X, LIU Y, ZHOU H, YANG M, ZHENG H, LI S and CAO J (2023) Causal effects of circulating vitamin levels on the risk of heart failure: a Mendelian randomization study, Journal of Geriatric Cardiology, 10.26599/1671-5411.2023.03.007, 20:3, (195-204), Online publication date: 1-Mar-2023.

Wang Y, Wang H, Zhang L, Zhang J, Liu N and Zhao P (2022) A novel identified circular RNA, circSnap47, promotes heart failure progression via regulation of miR-223-3p/MAPK axis, Molecular and Cellular Biochemistry, 10.1007/s11010-022-04523-z, 478:3, (459-469), Online publication date: 1-Mar-2023.

Abohelwa M, Kopel J, Shurmur S, Ansari M, Awasthi Y and Awasthi S (2023) The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review, Journal of Vascular Diseases, 10.3390/jvd2010010, 2:1, (122-164)

Dimosiari A, Patoulias D, Kitas G and Dimitroulas T (2023) Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence, Journal of Clinical Medicine, 10.3390/jcm12041302, 12:4, (1302)

Rosenblum S (2023) Inflammation, dysregulated iron metabolism, and cardiovascular disease, Frontiers in Aging, 10.3389/fragi.2023.1124178, 4

Paraskevaidis I, Farmakis D, Papingiotis G and Tsougos E (2023) Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy, Journal of Cardiovascular Development and Disease, 10.3390/jcdd10010019, 10:1, (19)

Parker W, Annabathula R, Skipina T and Soliman E (2022) Associations of empirical dietary inflammatory index with heart failure in adults from the United States, European Journal of Clinical Nutrition, 10.1038/s41430-022-01198-z, 77:1, (112-115), Online publication date: 1-Jan-2023.

Fathieh S, Grieve S, Negishi K and Figtree G (2023) Potential Biological Mediators of Myocardial and Vascular Complications of Air Pollution—A State-of-the-Art Review, Heart, Lung and Circulation, 10.1016/j.hlc.2022.11.014, 32:1, (26-42), Online publication date: 1-Jan-2023.

Mohan I, Baba K, Iyyapu R, Thirumalasetty S and Satish O (2023) Advances in congestive heart failure biomarkers , 10.1016/bs.acc.2022.09.005, (205-248), .

Park J, Yoon M, Cho H, Cho H, Kim K, Yang D, Yoo B, Kang S, Baek S, Jeon E, Kim J, Cho M, Chae S, Oh B and Choi D (2022) C-reactive protein and statins in heart failure with reduced and preserved ejection fraction, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.1064967, 9

Horvath C and Kararigas G (2022) Sex-Dependent Mechanisms of Cell Death Modalities in Cardiovascular Disease, Canadian Journal of Cardiology, 10.1016/j.cjca.2022.09.015, 38:12, (1844-1853), Online publication date: 1-Dec-2022.

Sinha A, Sitlani C, Doyle M, Fohner A, Buzkova P, Floyd J, Huber S, Olson N, Njoroge J, Kizer J, Delaney J, Shah S, Tracy R, Psaty B and Feinstein M (2022) Association of immune cell subsets with incident heart failure in two population‐based cohorts, ESC Heart Failure, 10.1002/ehf2.14140, 9:6, (4177-4188), Online publication date: 1-Dec-2022.

Remmelzwaal S, van Oort S, Handoko M, van Empel V, Heymans S and Beulens J (2022) Inflammation and heart failure: a two-sample Mendelian randomization study, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000001373, 23:11, (728-735), Online publication date: 1-Nov-2022.

Prakoso D, De Blasio M, Tate M and Ritchie R (2022) Current landscape of preclinical models of diabetic cardiomyopathy, Trends in Pharmacological Sciences, 10.1016/j.tips.2022.04.005, 43:11, (940-956), Online publication date: 1-Nov-2022.

Molinsky R, Yuzefpolskaya M, Norby F, Yu B, Shah A, Pankow J, Ndumele C, Lutsey P, Papapanou P, Beck J, Colombo P and Demmer R (2022) Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure, JACC: Heart Failure, 10.1016/j.jchf.2022.05.008, 10:10, (731-741), Online publication date: 1-Oct-2022.

Forcina L, Franceschi C and Musarò A (2022) The hormetic and hermetic role of IL-6, Ageing Research Reviews, 10.1016/j.arr.2022.101697, 80, (101697), Online publication date: 1-Sep-2022.

ÇELİK M, KÜP A, DEMİR S, GÜLŞEN K, İZCİ S, YILMAZ A, YILMAZ Y, ÇELİK F, KAHRAMAN F, TANIRCAN M, ÖZGEYİK M and USLU A (2022) Kardiyak Resenkronizasyon Tedavisine Yanıtın Öngörülmesinde Sistemik Bağışıklık-İnflamatuvar İndeksinin Rolü, Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 10.36516/jocass.1139629, 5:2, (145-154)

Leerink J, Feijen E, Moerland P, de Baat E, Merkx R, van der Pal H, Tissing W, Louwerens M, van den Heuvel‐Eibrink M, Versluys A, Asselbergs F, Sammani A, Teske A, van Dalen E, van der Heiden‐van der Loo M, van Dulmen‐den Broeder E, de Vries A, Kapusta L, Loonen J, Pinto Y, Kremer L, Mavinkurve‐Groothuis A and Kok W (2022) Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study, Journal of the American Heart Association, 11:14, Online publication date: 19-Jul-2022.

Zhao B, Bouchareb R and Lebeche D (2021) Resistin deletion protects against heart failure injury by targeting DNA damage response, Cardiovascular Research, 10.1093/cvr/cvab234, 118:8, (1947-1963), Online publication date: 29-Jun-2022.

Guardino C, Pan S, Vasan R, Xanthakis V and Proctor S (2022) Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study, PLOS ONE, 10.1371/journal.pone.0268576, 17:5, (e0268576)

Omran F, Kyrou I, Osman F, Lim V, Randeva H and Chatha K (2022) Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future, International Journal of Molecular Sciences, 10.3390/ijms23105680, 23:10, (5680)

Moshensky A, Brand C, Alhaddad H, Shin J, Masso-Silva J, Advani I, Gunge D, Sharma A, Mehta S, Jahan A, Nilaad S, Olay J, Gu W, Simonson T, Almarghalani D, Pham J, Perera S, Park K, Al-Kolla R, Moon H, Das S, Byun M, Shah Z, Sari Y, Heller Brown J and Crotty Alexander L (2022) Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice, eLife, 10.7554/eLife.67621, 11

Bezgin T, Çelik A, Karagöz A, Baytuğan N, Çağdaş M, Karakoyun S and Kaymaz C (2022) Prognostic Impact of Modified Glasgow Prognostic Score in Patients with Heart Failure with Mildly Reduced Ejection Fraction, Koşuyolu Heart Journal, 10.51645/khj.2022.m221, 25:1, (6-13)

Diab A, Valenzuela Ripoll C, Guo Z and Javaheri A (2022) HDL Composition, Heart Failure, and Its Comorbidities, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.846990, 9

Fopiano K, Jalnapurkar S, Davila A, Arora V and Bagi Z Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms, Current Cardiology Reviews, 10.2174/1573403X17666210831144651, 18:2

Hu C, Zhang X, Hu M, Teng T, Yuan Y, Song P, Kong C, Xu S, Ma Z and Tang Q (2022) Fibronectin type III domain‐containing 5 improves aging‐related cardiac dysfunction in mice, Aging Cell, 10.1111/acel.13556, 21:3, Online publication date: 1-Mar-2022.

Akhabue E, Wong M, Mehta R, Isakova T, Wolf M, Yancy C, Gutierrez O and Carnethon M (2022) Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study, American Heart Journal, 10.1016/j.ahj.2021.11.009, 245, (10-18), Online publication date: 1-Mar-2022.

Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C and Emdin M (2021) Biomarkers for the diagnosis and management of heart failure, Heart Failure Reviews, 10.1007/s10741-021-10105-w, 27:2, (625-643), Online publication date: 1-Mar-2022.

Paul P, Picard C, Lyonnet L, Resseguier N, Hubert L, Arnaud L, Di Cristofaro J, Laine M, Paganelli F, Dignat-George F, Frère C, Sabatier F, Guieu R and Bonello L (2022) FCGR2A-HH Gene Variants Encoding the Fc Gamma Receptor for the C-Reactive Protein Are Associated with Enhanced Monocyte CD32 Expression and Cardiovascular Events’ Recurrence after Primary Acute Coronary Syndrome, Biomedicines, 10.3390/biomedicines10020495, 10:2, (495)

Gáspár R, Halmi D, Demján V, Berkecz R, Pipicz M and Csont T (2022) Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease, Frontiers in Immunology, 10.3389/fimmu.2021.768560, 12

Gálvez B, Martinez-Perez C, Villa-Collar C, Alvarez-Peregrina C and Sánchez-Tena M (2022) Influence of Cytokines on Inflammatory Eye Diseases: A Citation Network Study, Journal of Clinical Medicine, 10.3390/jcm11030661, 11:3, (661)

李国 (2022) Recent Advances in Anxiety Disorders and Cardiovascular Diseases, Advances in Clinical Medicine, 10.12677/ACM.2022.124379, 12:04, (2638-2644), .

Tarokh A and Hosseini M (2022) Biomarker sensing using luminescent metal nanoclusters Luminescent Metal Nanoclusters, 10.1016/B978-0-323-88657-4.00008-9, (435-464), .

Darche F, Biener M, Müller-Hennessen M, Rivinius R, Stoyanov K, Milles B, Katus H, Frey N and Giannitsis E (2021) Low-Level Elevations of Procalcitonin Are Associated with Increased Mortality in Acute Heart Failure Patients, Independent of Concomitant Infection, Life, 10.3390/life11121429, 11:12, (1429)

Tai H, Jiang X, Lan Z, Li Y, Kong L, Yao S, Song N, Lv M, Wu J, Yang P, Xiao X, Yang G, Kuang J and Jia L (2021) Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats, BMC Complementary Medicine and Therapies, 10.1186/s12906-021-03270-w, 21:1, Online publication date: 1-Dec-2021.

COHEN A, TERAMOTO K, CLAGGETT B, BUCKLEY L, SOLOMON S, BALLANTYNE C, SELVIN E and SHAH A (2021) Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life, Journal of Cardiac Failure, 10.1016/j.cardfail.2021.07.006, 27:12, (1382-1392), Online publication date: 1-Dec-2021.

Furuhashi M, Muranaka A, Yuda S, Tanaka M, Koyama M, Kawamukai-Nishida M, Takahashi S, Higashiura Y, Miyamori D, Nishikawa R, Ohnishi H, Saitoh S, Shimamoto K and Miura T (2021) Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication, The American Journal of Cardiology, 10.1016/j.amjcard.2021.07.047, 158, (139-146), Online publication date: 1-Nov-2021.

Schiattarella G, Sequeira V and Ameri P (2020) Distinctive patterns of inflammation across the heart failure syndrome, Heart Failure Reviews, 10.1007/s10741-020-09949-5, 26:6, (1333-1344), Online publication date: 1-Nov-2021.

Prausmüller S, Spinka G, Arfsten H, Stasek S, Rettl R, Bartko P, Goliasch G, Strunk G, Riebandt J, Mascherbauer J, Bonderman D, Hengstenberg C, Hülsmann M and Pavo N (2021) Relevance of Neutrophil Neprilysin in Heart Failure, Cells, 10.3390/cells10112922, 10:11, (2922)

Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A and Sousa T (2021) Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets, Frontiers in Physiology, 10.3389/fphys.2021.746494, 12

Angkananard T, Inthanoo T, Sricholwattana S, Rattanajaruskul N, Wongsoasu A, Roongsangmanoon W and Aminuddin A (2021) The Predictive role of Neutrophil-to-Lymphocyte Ratio (NLR) and Mean Platelet Volume-to-Lymphocyte Ratio (MPVLR) for Cardiovascular Events in Adult Patients with Acute Heart Failure, Mediators of Inflammation, 10.1155/2021/6889733, 2021, (1-12), Online publication date: 11-Oct-2021.

Chen X, Huang W, Zhao L, Li Y, Wang L, Mo F and Guo W (2021) Relationship Between the Eosinophil/Monocyte Ratio and Prognosis in Decompensated Heart Failure: A Retrospective Study, Journal of Inflammation Research, 10.2147/JIR.S325229, Volume 14, (4687-4696)

Zhou W, Teklu M, Bui V, Manyak G, Kapoor P, Dey A, Sorokin A, Patel N, Teague H, Playford M, Erb-Alvarez J, Rodante J, Keel A, Shanbhag S, Hsu L, Bluemke D, Chen M, Carlsson M and Mehta N (2021) The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified coronary artery disease burden in psoriasis, American Journal of Preventive Cardiology, 10.1016/j.ajpc.2021.100211, 7, (100211), Online publication date: 1-Sep-2021.

Çinier G, Hayıroğlu M, Kolak Z, Tezen O, Yumurtaş A, Pay L, Eren S, Çetin T, Özcan S, Türkkan C, Özbilgin N, Tekkeşin A, Alper A and Gürkan K (2021) The value of C‐reactive protein‐to‐albumin ratio in predicting long‐term mortality among HFrEF patients with implantable cardiac defibrillators, European Journal of Clinical Investigation, 10.1111/eci.13550, 51:8, Online publication date: 1-Aug-2021.

Ju C, Zhou J, Lee S, Tan M, Liu T, Bazoukis G, Jeevaratnam K, Chan E, Wong I, Wei L, Zhang Q and Tse G (2021) Derivation of an electronic frailty index for predicting short‐term mortality in heart failure: a machine learning approach, ESC Heart Failure, 10.1002/ehf2.13358, 8:4, (2837-2845), Online publication date: 1-Aug-2021.

Itagaki T, Motoki H, Otagiri K, Machida K, Takeuchi T, Kanai M, Kimura K, Higuchi S, Minamisawa M, Kitabayashi H and Kuwahara K (2021) Inflammation-based assessment for the risk stratification of mortality in patients with heart failure, Scientific Reports, 10.1038/s41598-021-94525-6, 11:1

Sinha A, Rivera A, Doyle M, Sitlani C, Fohner A, Huber S, Olson N, Lima J, Delaney J, Feinstein M, Shah S, Tracy R and Psaty B (2021) Association of immune cell subsets with cardiac mechanics in the Multi-Ethnic Study of Atherosclerosis, JCI Insight, 10.1172/jci.insight.149193, 6:13, Online publication date: 8-Jul-2021.

Myhre P, Lyngbakken M, Berge T, Røysland R, Aagaard E, Pervez O, Kvisvik B, Brynildsen J, Norseth J, Tveit A, Steine K, Omland T and Røsjø H (2021) Diagnostic Thresholds for Pre–Diabetes Mellitus and Diabetes Mellitus and Subclinical Cardiac Disease in the General Population: Data From the ACE 1950 Study, Journal of the American Heart Association, 10:11, Online publication date: 1-Jun-2021.
Ridker P and Rane M (2021) Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease, Circulation Research, 128:11, (1728-1746), Online publication date: 28-May-2021.

McKechnie D, Papacosta A, Lennon L, Welsh P, Whincup P and Wannamethee S (2021) Inflammatory markers and incident heart failure in older men: the role of NT-proBNP, Biomarkers in Medicine, 10.2217/bmm-2020-0669, 15:6, (413-425), Online publication date: 1-Apr-2021.

Lagan J, Naish J, Fortune C, Bradley J, Clark D, Niven R, Chaudhuri N, Schelbert E, Schmitt M and Miller C (2020) Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance, The International Journal of Cardiovascular Imaging, 10.1007/s10554-020-02091-1, 37:4, (1371-1381), Online publication date: 1-Apr-2021.

Kwak S, Kwon S, Lee S, Yang S, Lee H, Lee H, Park J, Han K, Kim Y and Kim H (2021) Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study, Journal of Cardiology, 10.1016/j.jjcc.2020.07.026, 77:3, (231-238), Online publication date: 1-Mar-2021.

Curley S, Gall J, Byrne R, Yvan‐Charvet L and McGillicuddy F (2020) Metabolic Inflammation in Obesity—At the Crossroads between Fatty Acid and Cholesterol Metabolism, Molecular Nutrition & Food Research, 10.1002/mnfr.201900482, 65:1, Online publication date: 1-Jan-2021.

Azam M, Rahayu S, Fibriana A, Susanto H, Kartasurya M and Bahrudin U (2020) Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study, Asian Journal of Sports Medicine, 10.5812/asjsm.107053, 11:4

Meyre P and Conen D (2020) Does tooth brushing protect from atrial fibrillation and heart failure?, European Journal of Preventive Cardiology, 10.1177/2047487319886413, 27:17, (1832-1834), Online publication date: 1-Nov-2020.

Traxler D, Zimmermann M, Simader E, Veraar C, Moser B, Mueller T, Mildner M, Dannenberg V, Lainscak M, Jug B and Ankersmit H (2020) The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients, Clinica Chimica Acta, 10.1016/j.cca.2020.07.050, 510, (507-514), Online publication date: 1-Nov-2020.

Chen C, Zong M, Lu Y, Guo Y, Lv H, Xie L, Fu Z, Cheng Y, Si Y, Ye B and Fan L (2020) Differentially expressed lnc‐NOS2P3‐miR‐939‐5p axis in chronic heart failure inhibits myocardial and endothelial cells apoptosis via iNOS/TNFα pathway, Journal of Cellular and Molecular Medicine, 10.1111/jcmm.15740, 24:19, (11381-11396), Online publication date: 1-Oct-2020.

Sanchez A, Germany R, Lozier M, Schweitzer M, Kosseifi S and Anand R (2020) Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications, IJC Heart & Vasculature, 10.1016/j.ijcha.2020.100527, 30, (100527), Online publication date: 1-Oct-2020.

Tan Y, Zhang Z, Zheng C, Wintergerst K, Keller B and Cai L (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence, Nature Reviews Cardiology, 10.1038/s41569-020-0339-2, 17:9, (585-607), Online publication date: 1-Sep-2020.

Drakopoulou M, Soulaidopoulos S, Oikonomou G, Tousoulis D and Toutouzas K Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Current Vascular Pharmacology, 10.2174/1570161118666200214115532, 18:5, (488-506)

Krychtiuk K, Wurm R, Ruhittel S, Lenz M, Huber K, Wojta J, Heinz G, Hülsmann M and Speidl W (2020) Release of mitochondrial DNA is associated with mortality in severe acute heart failure, European Heart Journal. Acute Cardiovascular Care, 10.1177/2048872618823405, 9:5, (419-428), Online publication date: 1-Aug-2020.

Groenewegen A, Rutten F, Mosterd A and Hoes A (2020) Epidemiology of heart failure, European Journal of Heart Failure, 10.1002/ejhf.1858, 22:8, (1342-1356), Online publication date: 1-Aug-2020.

Fernandez C, Rysä J, Ström K, Nilsson J, Engström G, Orho‐Melander M, Ruskoaho H and Melander O (2020) Circulating protein biomarkers predict incident hypertensive heart failure independently of N‐terminal pro‐B‐type natriuretic peptide levels, ESC Heart Failure, 10.1002/ehf2.12757, 7:4, (1891-1899), Online publication date: 1-Aug-2020.

Suhrs H, Schroder J, Bové K, Mygind N, Frestad D, Michelsen M, Lange T, Gustafsson I, Kastrup J, Prescott E and De Rosa S (2020) Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?, PLOS ONE, 10.1371/journal.pone.0236035, 15:7, (e0236035)

Mayyas F, Aljohmani A and Alzoubi K The Impact of Spironolactone on Markers of Myocardial Oxidative Status, Inflammation and Remodeling in Hyperthyroid Rats, Current Molecular Pharmacology, 10.2174/1874467212666191113150553, 13:3, (206-215)

Meindl C, Hochadel M, Frankenstein L, Bruder O, Pauschinger M, Hambrecht R, von Scheidt W, Pfister O, Hartmann A, Maier L, Senges J, Unsöld B and den Uil C (2020) The role of diabetes in cardiomyopathies of different etiologies—Characteristics and 1-year follow-up results of the EVITA-HF registry, PLOS ONE, 10.1371/journal.pone.0234260, 15:6, (e0234260)

Al-Kindi S, Buzkova P, Shitole S, Reiner A, Garg P, Gottdiener J, Psaty B and Kizer J (2020) Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults, Journal of Cardiac Failure, 10.1016/j.cardfail.2020.03.003, 26:5, (410-419), Online publication date: 1-May-2020.

Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell B and Dinarello C (2020) Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease, Circulation Research, 126:9, (1260-1280), Online publication date: 24-Apr-2020.

Driggin E, Helmke S, De Los Santos J, Teruya S, Guadalupe S, Goldsmith J and Maurer M (2019) Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype, Amyloid, 10.1080/13506129.2019.1698417, 27:2, (73-80), Online publication date: 2-Apr-2020.

Cho A, Arfsten H, Goliasch G, Bartko P, Wurm R, Strunk G, Hülsmann M and Pavo N (2020) The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients, ESC Heart Failure, 10.1002/ehf2.12625, 7:2, (654-662), Online publication date: 1-Apr-2020.

Bakhshi H, Varadarajan V, Ambale‐Venkatesh B, Meyghani Z, Ostovaneh M, Durda P, Wu C, Tracy R, Cushman M, Bluemke D and Lima J (2020) Association of soluble interleukin‐2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi‐Ethnic Study of Atherosclerosis, ESC Heart Failure, 10.1002/ehf2.12623, 7:2, (639-644), Online publication date: 1-Apr-2020.

Sun S, Cao H, Yao N, Zhao L, Zhu X, Ni E, Zhu Q and Zhu W (2019) β-Arrestin 2 mediates arginine vasopressin-induced IL-6 induction via the ERK1/2-NF-κB signal pathway in murine hearts, Acta Pharmacologica Sinica, 10.1038/s41401-019-0292-y, 41:2, (198-207), Online publication date: 1-Feb-2020.

Chaikijurajai T and Tang W (2020) Reappraisal of Inflammatory Biomarkers in Heart Failure, Current Heart Failure Reports, 10.1007/s11897-019-00450-1, 17:1, (9-19), Online publication date: 1-Feb-2020.

Venkatesh H, Ravish H, Delphine Silvia C and Srinivas H (2020) Molecular signature of the immune response to yoga therapy in stress-related chronic disease conditions: An insight, International Journal of Yoga, 10.4103/ijoy.IJOY_82_18, 13:1, (9), .

Li C, Xia W, Wang L, Zhang J, He Q, Liu Y, Xia D and Lu C (2020)(2020) Effect of Renal Denervation on Cardiac Function and Inflammatory Factors in Heart Failure After Myocardial Infarction, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000899, 76:5, (602-609)

Ong L (2020)(2020) The Association Between Pneumonia and Heart failure, Clinical Pulmonary Medicine, 10.1097/CPM.0000000000000371, 27:5, (125-130)

Fusar-Poli L and Arillotta D (2020) Anxiety, Anger, Personality, and Heart Disease Brain and Heart Dynamics, 10.1007/978-3-319-90305-7_19-1, (1-18), .

Fusar-Poli L and Arillotta D (2020) Anxiety, Anger, Personality, and Heart Disease Brain and Heart Dynamics, 10.1007/978-3-030-28008-6_19, (243-260), .

Lanser L, Pölzl G, Fuchs D, Weiss G and Kurz K (2019) Neopterin is Associated with Disease Severity and Outcome in Patients with Non-Ischaemic Heart Failure, Journal of Clinical Medicine, 10.3390/jcm8122230, 8:12, (2230)

Matsumoto H, Kasai T, Sato A, Ishiwata S, Yatsu S, Shitara J, Murata A, Kato T, Suda S, Matsue Y, Hiki M, Takagi A and Daida H (2019) Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure, Heart and Vessels, 10.1007/s00380-019-01435-9, 34:12, (1961-1968), Online publication date: 1-Dec-2019.

Wu B, Huang X, Li L, Fan X, Li P, Huang C, Xiao J, Gui R and Wang S (2019) Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model, Journal of Cellular and Molecular Medicine, 10.1111/jcmm.14638, 23:11, (7651-7663), Online publication date: 1-Nov-2019.

Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, Acheampong E, Zhengcan Z, Xiaoyan Q, Yunsheng X, Jingyuan M, Xiumei G and Guanwei F (2019) Biomarkers in heart failure: the past, current and future, Heart Failure Reviews, 10.1007/s10741-019-09807-z, 24:6, (867-903), Online publication date: 1-Nov-2019.

Armutcu F (2019) Organ crosstalk: the potent roles of inflammation and fibrotic changes in the course of organ interactions, Inflammation Research, 10.1007/s00011-019-01271-7, 68:10, (825-839), Online publication date: 1-Oct-2019.

Filardi T, Ghinassi B, Di Baldassarre A, Tanzilli G, Morano S, Lenzi A, Basili S and Crescioli C (2019) Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte, International Journal of Molecular Sciences, 10.3390/ijms20133299, 20:13, (3299)

Everett B, Cornel J, Lainscak M, Anker S, Abbate A, Thuren T, Libby P, Glynn R and Ridker P (2018) Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure, Circulation, 139:10, (1289-1299), Online publication date: 5-Mar-2019.

Everett B and Siddiqi H (2019) Heart Failure, the Inflammasome, and Interleukin-1β, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.01.005, 73:9, (1026-1028), Online publication date: 1-Mar-2019.

Ne J, Chow V, Kritharides L and Ng A (2019) Predictors for congestive heart failure hospitalization or death following acute pulmonary embolism: A population-linkage study, International Journal of Cardiology, 10.1016/j.ijcard.2018.12.063, 278, (162-166), Online publication date: 1-Mar-2019.

Reznik E and Nikitin I (2019) CARDIORENAL SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE AS A STAGE OF THE CARDIORENAL CONTINUUM (PART I): DEFINITION, CLASSIFICATION, PATHOGENESIS, DIAGNOSIS, EPIDEMIOLOGY, The Russian Archives of Internal Medicine, 10.20514/2226-6704-2019-9-1-5-22, 9:1, (5-22)

Milajerdi A, Djafarian K, Shab‐Bidar S and Speakman J (2018) Pre‐ and post‐diagnosis body mass index and heart failure mortality: a dose–response meta‐analysis of observational studies reveals greater risk of being underweight than being overweight, Obesity Reviews, 10.1111/obr.12777, 20:2, (252-261), Online publication date: 1-Feb-2019.

Coronado M, Bruno K, Blauwet L, Tschöpe C, Cunningham M, Pankuweit S, van Linthout S, Jeon E, McNamara D, Krejčí J, Bienertová‐Vašků J, Douglass E, Abston E, Bucek A, Frisancho J, Greenaway M, Hill A, Schultheiss H, Cooper L and Fairweather D (2019) Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis, Journal of the American Heart Association, 8:2, Online publication date: 22-Jan-2019.

Bonda T, Dziemidowicz M, Cieślińska M, Tarasiuk E, Wawrusiewicz-Kurylonek N, Bialuk I, Winnicka M and Kamiński K (2018) Interleukin 6 Knockout Inhibits Aging-Related Accumulation of p53 in the Mouse Myocardium, The Journals of Gerontology: Series A, 10.1093/gerona/gly105, 74:2, (176-182), Online publication date: 16-Jan-2019.

Lyngbakken M, Myhre P, Røsjø H and Omland T (2018) Novel biomarkers of cardiovascular disease: Applications in clinical practice, Critical Reviews in Clinical Laboratory Sciences, 10.1080/10408363.2018.1525335, 56:1, (33-60), Online publication date: 2-Jan-2019.

Woulfe K and Bruns D (2019) From pediatrics to geriatrics: Mechanisms of heart failure across the life-course, Journal of Molecular and Cellular Cardiology, 10.1016/j.yjmcc.2018.11.009, 126, (70-76), Online publication date: 1-Jan-2019.

Stanciu A (2019) Cytokines in heart failure , 10.1016/bs.acc.2019.07.002, (63-113), .

van Wezenbeek J, Canada J, Ravindra K, Carbone S, Trankle C, Kadariya D, Buckley L, Del Buono M, Billingsley H, Viscusi M, Wohlford G, Arena R, Van Tassell B and Abbate A (2018) C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2018.00178, 5

Panico C and Condorelli G (2017) Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases, Clinical Reviews in Allergy & Immunology, 10.1007/s12016-017-8624-5, 55:3, (254-270), Online publication date: 1-Dec-2018.

Yogasundaram H, Nikhanj A, Putko B, Boutin M, Jain‐Ghai S, Khan A, Auray‐Blais C, West M and Oudit G (2018) Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction, Journal of the American Heart Association, 7:21, Online publication date: 6-Nov-2018.

Novikova D, Kirillova I, Udachkina H and Popkova T (2018) Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2018-14-5-703-710, 14:5, (703-710)

Farzin L, Shamsipur M, Samandari L and Sheibani S (2018) Recent advances in designing nanomaterial based biointerfaces for electrochemical biosensing cardiovascular biomarkers, Journal of Pharmaceutical and Biomedical Analysis, 10.1016/j.jpba.2018.08.060, 161, (344-376), Online publication date: 1-Nov-2018.

Edmonston D, Morris J and Middleton J (2018) Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4, Advances in Chronic Kidney Disease, 10.1053/j.ackd.2018.08.010, 25:5, (454-467), Online publication date: 1-Sep-2018.

Silvestre O, Nadruz W, Querejeta Roca G, Claggett B, Solomon S, Mirabelli M, London S, Loehr L and Shah A (2018) Declining Lung Function and Cardiovascular Risk, Journal of the American College of Cardiology, 10.1016/j.jacc.2018.06.049, 72:10, (1109-1122), Online publication date: 1-Sep-2018.

Ergatoudes C, Thunström E, Hansson P, Morales D, Mandalenakis Z, Rosengren A, Zhong Y, Caidahl K and Fu M (2018) Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up, Journal of Cardiac Failure, 10.1016/j.cardfail.2018.07.005, 24:9, (594-600), Online publication date: 1-Sep-2018.

Rutten F (2018) Hartfalen en COPD, Bijblijven, 10.1007/s12414-018-0328-0, 34:6, (448-455), Online publication date: 1-Aug-2018.

Bobylev A, Rachina S, Avdeev S and Petrov A Diagnostic, clinical and prognostic aspects determine the concentration of C-reactive protein in chronic heart failure., Clinical Medicine (Russian Journal), 10.18821/0023-2149-2018-96-3-197-207, 96:3, (197-207)

Wilkinson J, Williams P, Yu W, Colan S, Mendez A, Zachariah J, Van Dyke R, Shearer W, Margossian R and Lipshultz S (2018) Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children, AIDS, 10.1097/QAD.0000000000001810, 32:10, (1267-1277), Online publication date: 19-Jun-2018.

Buckley L and Abbate A (2018) Interleukin-1 blockade in cardiovascular diseases: a clinical update, European Heart Journal, 10.1093/eurheartj/ehy128, 39:22, (2063-2069), Online publication date: 7-Jun-2018.

Baldassarre M, Andersen A, Consoli A, Knop F and Vilsbøll T (2018) Cardiovascular biomarkers in clinical studies of type 2 diabetes, Diabetes, Obesity and Metabolism, 10.1111/dom.13247, 20:6, (1350-1360), Online publication date: 1-Jun-2018.

Hangelbroek R, Knuiman P, Tieland M and de Groot L (2018) Attenuated strength gains during prolonged resistance exercise training in older adults with high inflammatory status, Experimental Gerontology, 10.1016/j.exger.2018.02.008, 106, (154-158), Online publication date: 1-Jun-2018.

Fluschnik N, Ojeda F, Zeller T, Jørgensen T, Kuulasmaa K, Becher P, Sinning C, Blankenberg S, Westermann D and Schäfer A (2018) Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease, PLOS ONE, 10.1371/journal.pone.0197497, 13:5, (e0197497)

Najjari M, Vaezi G, Hojati V, Mousavi Z, Bakhtiarian A and Nikoui V (2018) Involvement of IL-1β and IL-6 in antiarrhythmic properties of atorvastatin in ouabain-induced arrhythmia in rats, Immunopharmacology and Immunotoxicology, 10.1080/08923973.2018.1440592, 40:3, (256-261), Online publication date: 4-May-2018.

Moliner P, Lupón J, Barallat J, de Antonio M, Domingo M, Núñez J, Zamora E, Galán A, Santesmases J, Pastor C and Bayes-Genis A (2018) Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction, International Journal of Cardiology, 10.1016/j.ijcard.2018.01.119, 257, (188-192), Online publication date: 1-Apr-2018.

Hohendanner F, Messroghli D, Bode D, Blaschke F, Parwani A, Boldt L and Heinzel F (2018) Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction, ESC Heart Failure, 10.1002/ehf2.12260, 5:2, (211-221), Online publication date: 1-Apr-2018.

Kentaro S, Kimiharu I, Sari M, Shojiro T and Yuko K (2018) Exploration of Predictive Biomarkers for Sudden Unexplained Cardiac Death in Nonelderly People, American Journal of Forensic Medicine & Pathology, 10.1097/PAF.0000000000000361, 39:1, (41-45), Online publication date: 1-Mar-2018.

Burrai F, Hasan W, Luppi M and Micheluzzi V (2018) A Conceptual Framework Encompassing the Psychoneuroimmunoendocrinological Influences of Listening to Music in Patients With Heart Failure, Holistic Nursing Practice, 10.1097/HNP.0000000000000253, 32:2, (81-89), Online publication date: 1-Mar-2018.

Zhong B, Rubinstein J, Ma S and Wang D (2018) Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2018.01.065, 99, (261-270), Online publication date: 1-Mar-2018.

Potier F, Degryse J and de Saint-Hubert M (2017) Impact of caregiving for older people and pro-inflammatory biomarkers among caregivers: a systematic review, Aging Clinical and Experimental Research, 10.1007/s40520-017-0765-0, 30:2, (119-132), Online publication date: 1-Feb-2018.

Choi J and McCarthy M (2017) Novel applications for serum procalcitonin testing in clinical practice, Expert Review of Molecular Diagnostics, 10.1080/14737159.2018.1407244, 18:1, (27-34), Online publication date: 2-Jan-2018.

Wang C, Fang X, Hua Y, Liu Y, Zhang Z, Gu X, Wu X, Tang Z, Guan S, Liu H, Liu B, Guo X and Ji X (2017) Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China, Angiology, 10.1177/0003319717704554, 69:1, (49-58), Online publication date: 1-Jan-2018.

Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber R, Behr J, Wacker M, Biertz F, Watz H, Bals R, Welte T, Wirtz H, Herth F, Vestbo J, Wouters E, Vogelmeier C and Jörres R (2018) The revised GOLD 2017 COPD categorization in relation to comorbidities, Respiratory Medicine, 10.1016/j.rmed.2017.12.003, 134, (79-85), Online publication date: 1-Jan-2018.

Iwatsuka R, Matsue Y, Yonetsu T, O'uchi T, Matsumura A, Hashimoto Y and Hirao K (2018) Arterial inflammation measured by 18F-FDG-PET-CT to predict coronary events in older subjects, Atherosclerosis, 10.1016/j.atherosclerosis.2017.11.016, 268, (49-54), Online publication date: 1-Jan-2018.

Lavine K and Mann D (2018) Inflammatory Mediators in Heart Failure Heart Failure in the Child and Young Adult, 10.1016/B978-0-12-802393-8.00003-X, (33-50), .

Cochran T, Franco V, Scully R and Lipshultz S (2018) Anthracycline, Trastuzumab, and Cardiovascular Toxicity Comprehensive Toxicology, 10.1016/B978-0-12-801238-3.95641-1, (432-446), .

Terziyski K and Draganova A (2018) Central Sleep Apnea with Cheyne-Stokes Breathing in Heart Failure – From Research to Clinical Practice and Beyond Heart Failure: From Research to Clinical Practice, 10.1007/5584_2018_146, (327-351), .

Natali A, Nesti L, Fabiani I, Calogero E and Di Bello V (2017) Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial, Cardiovascular Diabetology, 10.1186/s12933-017-0615-6, 16:1, Online publication date: 1-Dec-2017.

Adams V, Linke A and Winzer E (2017) Skeletal muscle alterations in HFrEF vs. HFpEF, Current Heart Failure Reports, 10.1007/s11897-017-0361-9, 14:6, (489-497), Online publication date: 1-Dec-2017.

Crump C, Sundquist J, Winkleby M and Sundquist K (2017) Aerobic fitness, muscular strength and obesity in relation to risk of heart failure, Heart, 10.1136/heartjnl-2016-310716, 103:22, (1780-1787), Online publication date: 1-Nov-2017.

Selim A, Zolty R and Chatzizisis Y (2017) The evolution of heart failure with reduced ejection fraction pharmacotherapy: What do we have and where are we going?, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2017.03.011, 178, (67-82), Online publication date: 1-Oct-2017.

Sun M, Chang Q, Xin M, Wang Q, Li H and Qian J (2017) Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by interleukin 6 in vitro, International Journal of Immunopathology and Pharmacology, 10.1177/0394632016689571, 30:3, (227-237), Online publication date: 1-Sep-2017.

Xu F, Sun S, Wang X, Ni E, Zhao L and Zhu W (2017) GRK2 Mediates Arginine Vasopressin-Induced Interleukin-6 Production via Nuclear Factor-κB Signaling Neonatal Rat Cardiac Fibroblast, Molecular Pharmacology, 10.1124/mol.116.107698, 92:3, (278-284), Online publication date: 1-Sep-2017.

Lin H and Zhang Y (2017) The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients, International Journal of Cardiology, 10.1016/j.ijcard.2016.10.083, 242, (1-3), Online publication date: 1-Sep-2017.

Van Tassell B, Buckley L, Carbone S, Trankle C, Canada J, Dixon D, Abouzaki N, Oddi‐Erdle C, Biondi‐Zoccai G, Arena R and Abbate A (2017) Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐ HART2 ) , Clinical Cardiology, 10.1002/clc.22719, 40:9, (626-632), Online publication date: 1-Sep-2017.

Mohan M, Vasudevan N and Naga Prasad S (2017) Proinflammatory Cytokines Mediate GPCR Dysfunction, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000456, 70:2, (61-73), Online publication date: 1-Aug-2017.

Van Linthout S and Tschöpe C (2017) Inflammation – Cause or Consequence of Heart Failure or Both?, Current Heart Failure Reports, 10.1007/s11897-017-0337-9, 14:4, (251-265), Online publication date: 1-Aug-2017.

Möckel M, Searle J and Maisel A (2017) The role of procalcitonin in acute heart failure patients, ESC Heart Failure, 10.1002/ehf2.12189, 4:3, (203-208), Online publication date: 1-Aug-2017.

Tromp J, Khan M, Mentz R, O’Connor C, Metra M, Dittrich H, Ponikowski P, Teerlink J, Cotter G, Davison B, Cleland J, Givertz M, Bloomfield D, Van Veldhuisen D, Hillege H, Voors A and van der Meer P (2017) Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction, JACC: Heart Failure, 10.1016/j.jchf.2017.04.007, 5:7, (507-517), Online publication date: 1-Jul-2017.

Shahrivari M, Wise E, Resende M, Shuster J, Zhang J, Bolli R, Cooke J, Hare J, Henry T, Khan A, Taylor D, Traverse J, Yang P, Pepine C and Cogle C (2017) Peripheral Blood Cytokine Levels After Acute Myocardial Infarction, Circulation Research, 120:12, (1947-1957), Online publication date: 9-Jun-2017.
Dou H, Feher A, Davila A, Romero M, Patel V, Kamath V, Gooz M, Rudic R, Lucas R, Fulton D, Weintraub N and Bagi Z (2017) Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction, Arteriosclerosis, Thrombosis, and Vascular Biology, 37:6, (1180-1193), Online publication date: 1-Jun-2017.

Duarte P, Duarte M, Pelichek A, Pfrimer K, Ferriolli E, Moriguti J and Lima N (2016) Cardiovascular risk factors and inflammatory activity among centenarians with and without dementia, Aging Clinical and Experimental Research, 10.1007/s40520-016-0603-9, 29:3, (411-417), Online publication date: 1-Jun-2017.

Shirazi L, Bissett J, Romeo F and Mehta J (2017) Role of Inflammation in Heart Failure, Current Atherosclerosis Reports, 10.1007/s11883-017-0660-3, 19:6, Online publication date: 1-Jun-2017.

AlBadri A, Lai K, Wei J, Landes S, Mehta P, Li Q, Johnson D, Reis S, Kelsey S, Bittner V, Sopko G, Shaw L, Pepine C, Bairey Merz C and Bugiardini R (2017) Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE), PLOS ONE, 10.1371/journal.pone.0177684, 12:5, (e0177684)

He J, Shlipak M, Anderson A, Roy J, Feldman H, Kallem R, Kanthety R, Kusek J, Ojo A, Rahman M, Ricardo A, Soliman E, Wolf M, Zhang X, Raj D, Hamm L, Appel L, Go A, Lash J and Townsend R (2017) Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study, Journal of the American Heart Association, 6:5, Online publication date: 5-May-2017.

Ni Mhuircheartaigh O, Crowson C, Gabriel S, Roger V, Melton L and Amin S (2017) Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study, The Journal of Rheumatology, 10.3899/jrheum.160651, 44:5, (558-564), Online publication date: 1-May-2017.

Lund N, Gränsbo K, Wernersson C and Melander O (2017) Cardiometabolic biomarkers are predictors of readmission and death in patients hospitalized for acute dyspnea, The American Journal of Emergency Medicine, 10.1016/j.ajem.2016.12.048, 35:4, (610-614), Online publication date: 1-Apr-2017.

Frati G, Schirone L, Chimenti I, Yee D, Biondi-Zoccai G, Volpe M and Sciarretta S (2017) An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy, Cardiovascular Research, 10.1093/cvr/cvx011, 113:4, (378-388), Online publication date: 15-Mar-2017., Online publication date: 15-Mar-2017.

Kupsky D, Ahmed A, Sakr S, Qureshi W, Brawner C, Blaha M, Ehrman J, Keteyian S and Al-Mallah M (2017) Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project, American Heart Journal, 10.1016/j.ahj.2016.12.006, 185, (35-42), Online publication date: 1-Mar-2017.

Lavine K and Sierra O (2017) Skeletal muscle inflammation and atrophy in heart failure, Heart Failure Reviews, 10.1007/s10741-016-9593-0, 22:2, (179-189), Online publication date: 1-Mar-2017.

Chen Z, Qureshi A, Parini P, Hurt‐Camejo E, Ripsweden J, Brismar T, Barany P, Jaminon A, Schurgers L, Heimbürger O, Lindholm B and Stenvinkel P (2017) Does statins promote vascular calcification in chronic kidney disease?, European Journal of Clinical Investigation, 10.1111/eci.12718, 47:2, (137-148), Online publication date: 1-Feb-2017.

Yang G, Chen S, Ma A, Lu J and Wang T (2017) Identification of the difference in the pathogenesis in heart failure arising from different etiologies using a microarray dataset, Clinics, 10.6061/clinics/2017(10)03, 72:10, (600-608), .

Masudo R, Yasukawa K, Nojiri T, Yoshikawa N, Shimosaka H, Sone S, Oike Y, Ugawa A, Yamazaki T, Shimokado K, Yatomi Y and Ikeda H (2017) Evaluation of human nonmercaptalbumin as a marker for oxidative stress and its association with various parameters in blood, Journal of Clinical Biochemistry and Nutrition, 10.3164/jcbn.17-5, 61:2, (79-84), .

Ohuchi H, Hayama Y, Negishi J, Noritake K, Miyazaki A, Yamada O and Shiraishi I (2017) Determinants of Aortic Size and Stiffness and the Impact on Exercise Physiology in Patients After the Fontan Operation, International Heart Journal, 10.1536/ihj.16-183, 58:1, (73-80), .

Ibrahim N and Januzzi J (2017) Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure, Clinical Chemistry, 10.1373/clinchem.2016.259564, 63:1, (211-222), Online publication date: 1-Jan-2017.

Boulogne M, Sadoune M, Launay J, Baudet M, Cohen-Solal A and Logeart D (2017) Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction, International Journal of Cardiology, 10.1016/j.ijcard.2016.10.038, 226, (53-59), Online publication date: 1-Jan-2017.

Verjans R, van Bilsen M and Schroen B (2017) MiRNA Deregulation in Cardiac Aging and Associated Disorders MiRNAs in Aging and Cancer, 10.1016/bs.ircmb.2017.03.004, (207-263), .

Ohuchi H (2017) The Fontan Operation Aortopathy, 10.1007/978-4-431-56071-5_20, (313-323), .

Lenneman C, Kimmick G and Sawyer D (2017) Epidemiology of Cardio-Oncology Cardio-Oncology, 10.1007/978-3-319-43096-6_1, (1-14), .

Ambrosova T, Ashcheulova T and Kompaniiets K (2016) Роль адипонектину у генезі серцевої недостатності, Likarska sprava, 10.31640/LS-2016(7-8)03:7-8, (23-27)

Bozkurt B, Aguilar D, Deswal A, Dunbar S, Francis G, Horwich T, Jessup M, Kosiborod M, Pritchett A, Ramasubbu K, Rosendorff C and Yancy C (2016) Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association, Circulation, 134:23, (e535-e578), Online publication date: 6-Dec-2016.

Puzianowska-Kuźnicka M, Owczarz M, Wieczorowska-Tobis K, Nadrowski P, Chudek J, Slusarczyk P, Skalska A, Jonas M, Franek E and Mossakowska M (2016) Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study, Immunity & Ageing, 10.1186/s12979-016-0076-x, 13:1, Online publication date: 1-Dec-2016.

Kaplan P, Vrtovec B and Jug B (2016) Orosomucoid is an independent predictor of prognosis in chronic heart failure, Wiener klinische Wochenschrift, 10.1007/s00508-016-1034-5, 128:23-24, (870-874), Online publication date: 1-Dec-2016.

Han C, Ding D, Lopez M, Manohar S, Zhang Y, Kim M, Park H, White K, Kim Y, Linser P, Tanokura M, Leeuwenburgh C, Baker H, Salvi R and Someya S (2016) Effects of Long-Term Exercise on Age-Related Hearing Loss in Mice, The Journal of Neuroscience, 10.1523/JNEUROSCI.2493-16.2016, 36:44, (11308-11319), Online publication date: 2-Nov-2016.

Celano C, Daunis D, Lokko H, Campbell K and Huffman J (2016) Anxiety Disorders and Cardiovascular Disease, Current Psychiatry Reports, 10.1007/s11920-016-0739-5, 18:11, Online publication date: 1-Nov-2016.

O'NEAL W, SALAHUDDIN T, BROUGHTON S and SOLIMAN E (2016) Atrial Fibrillation and Cardiovascular Outcomes in the Elderly, Pacing and Clinical Electrophysiology, 10.1111/pace.12907, 39:9, (907-913), Online publication date: 1-Sep-2016.

Angulo J, El Assar M and Rodríguez-Mañas L (2016) Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults, Molecular Aspects of Medicine, 10.1016/j.mam.2016.06.001, 50, (1-32), Online publication date: 1-Aug-2016.

Dick S and Epelman S (2016) Chronic Heart Failure and Inflammation, Circulation Research, 119:1, (159-176), Online publication date: 24-Jun-2016.

Van Tassell B, Abouzaki N, Oddi Erdle C, Carbone S, Trankle C, Melchior R, Turlington J, Thurber C, Christopher S, Dixon D, Fronk D, Thomas C, Rose S, Buckley L, Dinarello C, Biondi-Zoccai G and Abbate A (2016) Interleukin-1 Blockade in Acute Decompensated Heart Failure, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000378, 67:6, (544-551), Online publication date: 1-Jun-2016.

Bambrick P, Tan W, Mulcahy R, Pope G and Cooke J (2016) Vascular risk assessment in older adults without a history of cardiovascular disease, Experimental Gerontology, 10.1016/j.exger.2016.03.002, 79, (37-45), Online publication date: 1-Jun-2016.

Hamo C and Butler J (2016) How to Best Identify Elderly Individuals Who May Develop Heart Failure, Current Cardiovascular Risk Reports, 10.1007/s12170-016-0500-y, 10:5, Online publication date: 1-May-2016.

Crane P, Efird J and Abel W (2016) Fatigue in Older Adults Postmyocardial Infarction, Frontiers in Public Health, 10.3389/fpubh.2016.00055, 4

Taveira T, Ouellette D, Gulum A, Choudhary G, Eaton C, Liu S and Wu W (2016) Relation of Magnesium Intake With Cardiac Function and Heart Failure Hospitalizations in Black Adults, Circulation: Heart Failure, 9:4, Online publication date: 1-Apr-2016.

Abbas A and Sakr H (2016) Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism, Canadian Journal of Physiology and Pharmacology, 10.1139/cjpp-2015-0247, 94:4, (426-432), Online publication date: 1-Apr-2016.

Sudharshana Murthy K, Ashoka H and Aparna A (2016) Evaluation and comparison of biomarkers in heart failure, Indian Heart Journal, 10.1016/j.ihj.2015.09.003, 68, (S22-S28), Online publication date: 1-Apr-2016.

Jandali B, Tang W and Husni E (2016) Heart Failure and Inflammatory Arthritis: the Relationship of Systemic Inflammation, Current Cardiovascular Risk Reports, 10.1007/s12170-016-0497-2, 10:4, Online publication date: 1-Apr-2016.

Szewieczek J, Gąsior Z, Duława J, Francuz T, Legierska K, Batko-Szwaczka A, Hornik B, Janusz-Jenczeń M, Włodarczyk I and Wilczyński K (2016) ECG low QRS voltage and wide QRS complex predictive of centenarian 360-day mortality, AGE, 10.1007/s11357-016-9907-0, 38:2, Online publication date: 1-Apr-2016.

Salvador A, Nevers T, Velázquez F, Aronovitz M, Wang B, Abadía Molina A, Jaffe I, Karas R, Blanton R and Alcaide P (2016) Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload–Induced Heart Failure, Journal of the American Heart Association, 5:3, Online publication date: 9-Mar-2016.

Li F, Lang F, Zhang H, Xu L, Wang Y and Hao E (2016) Role of TFEB Mediated Autophagy, Oxidative Stress, Inflammation, and Cell Death in Endotoxin Induced Myocardial Toxicity of Young and Aged Mice, Oxidative Medicine and Cellular Longevity, 10.1155/2016/5380319, 2016, (1-10), .

Lestari B, Permatasari N and Rohman M (2016) Methanolic Extract of Ceplukan Leaf ( Physalis minima L.) Attenuates Ventricular Fibrosis through Inhibition of TNF- α in Ovariectomized Rats , Advances in Pharmacological Sciences, 10.1155/2016/2428052, 2016, (1-7), .

Manhas A, Tripathi D, Biswas B, Ahmad H, Goyal D, Dwivedi A, Dikshit M and Jagavelu K (2016) Non-carbonyl Curcuma longa [NCCL] protects the heart from myocardial ischemia/reperfusion injury by reducing endothelial microparticle mediated inflammation in rats, RSC Advances, 10.1039/C6RA06858H, 6:60, (54938-54948)

Ikeda M, Nakao M, Hirano K, Yokoyama K, Yokoo T, Joki N, Ando R, Shinoda T, Inaguma D, Yamaka T, Komatsu Y, Koiwa F, Sakaguchi T, Negi S and Shigematsu T (2015) Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney disease, Journal of the Renin-Angiotensin-Aldosterone System, 10.1177/1470320315592565, 16:4, (1175-1184), Online publication date: 1-Dec-2015.

Bonsu K, Reidpath D and Kadirvelu A (2015) Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta‐Analysis of Randomized Trials, Cardiovascular Therapeutics, 10.1111/1755-5922.12150, 33:6, (338-346), Online publication date: 1-Dec-2015.

Silva N, Bettencourt P and Guimarães J (2015) The lymphocyte-to-monocyte ratio: An added value for death prediction in heart failure, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2015.07.004, 25:11, (1033-1040), Online publication date: 1-Nov-2015.

Lappegård K, Bjørnstad H, Mollnes T and Hovland A (2015) Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review, Scandinavian Journal of Immunology, 10.1111/sji.12328, 82:3, (191-198), Online publication date: 1-Sep-2015.

Adriaensen W, Matheï C, Vaes B, van Pottelbergh G, Wallemacq P and Degryse J (2015) Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study, Experimental Gerontology, 10.1016/j.exger.2015.06.005, 69, (53-61), Online publication date: 1-Sep-2015.

Corrales-Medina V, Taljaard M, Yende S, Kronmal R, Dwivedi G, Newman A, Elkind M, Lyles M and Chirinos J (2015) Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults, American Heart Journal, 10.1016/j.ahj.2015.04.028, 170:2, (306-312.e6), Online publication date: 1-Aug-2015.

Kenchaiah S and Vasan R (2015) Heart Failure in Women – Insights from the Framingham Heart Study, Cardiovascular Drugs and Therapy, 10.1007/s10557-015-6599-0, 29:4, (377-390), Online publication date: 1-Aug-2015.

Bose A, Truong Q and Singh J (2015) Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-015-9982-7, 43:1, (31-44), Online publication date: 1-Jun-2015.

Ren M, Li X, Hao L and Zhong J (2015) Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?, Annals of Medicine, 10.3109/07853890.2015.1042030, 47:4, (316-324), Online publication date: 19-May-2015.

Passino C, Barison A, Vergaro G, Gabutti A, Borrelli C, Emdin M and Clerico A (2015) Markers of fibrosis, inflammation, and remodeling pathways in heart failure, Clinica Chimica Acta, 10.1016/j.cca.2014.09.006, 443, (29-38), Online publication date: 1-Mar-2015.

Huynh K, Van Tassell B and Chow S (2015) Predicting therapeutic response in patients with heart failure: the story of C-reactive protein, Expert Review of Cardiovascular Therapy, 10.1586/14779072.2015.1000307, 13:2, (153-161), Online publication date: 1-Feb-2015.

Kunin M, Carmon V, Arad M, Levin-Iaina N, Freimark D, Holtzman E and Dinour D (2015) Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis, BioMed Research International, 10.1155/2015/590851, 2015, (1-8), .

Van Laecke S, Van Biesen W and Vanholder R (2014) The paradox of bardoxolone methyl: a call for every witness on the stand?, Diabetes, Obesity and Metabolism, 10.1111/dom.12356, 17:1, (9-14), Online publication date: 1-Jan-2015.

Pires A, Souza V, Paula R, Toledo J, Lins T, Moraes C, Córdova C, Pereira R and Nóbrega O (2015) Pro-inflammatory cytokines correlate with classical risk factors for atherosclerosis in the admixed Brazilian older women, Archives of Gerontology and Geriatrics, 10.1016/j.archger.2014.10.004, 60:1, (142-146), Online publication date: 1-Jan-2015.

Altara R and Blankesteijn W (2015) Technological Aspects of Measuring Inflammatory Markers Inflammation in Heart Failure, 10.1016/B978-0-12-800039-7.00008-6, (117-130), .

Frunza O and Frangogiannis N (2015) Inflammatory Biomarkers in Post-infarction Heart Failure and Cardiac Remodeling Inflammation in Heart Failure, 10.1016/B978-0-12-800039-7.00007-4, (105-116), .

Zouein F, DeCoux A, Tian Y, White J, Jin Y and Lindsey M (2015) Matrix Metalloproteinase 9 (MMP-9) Cardiac Fibrosis and Heart Failure: Cause or Effect?, 10.1007/978-3-319-17437-2_13, (237-259), .

Lui G, Fernandes S and McElhinney D (2014) Management of Cardiovascular Risk Factors in Adults With Congenital Heart Disease, Journal of the American Heart Association, 3:6, Online publication date: 17-Dec-2014.

Mitaka C, Si M, Tulafu M, Yu Q, Uchida T, Abe S, Kitagawa M, Ikeda S, Eishi Y and Tomita M (2014) Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury, Intensive Care Medicine Experimental, 10.1186/s40635-014-0028-8, 2:1, Online publication date: 1-Dec-2014.

Fuseya T, Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Mita T, Ishimura S, Watanabe Y, Hoshina K, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K and Miura T (2014) Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population, Cardiovascular Diabetology, 10.1186/s12933-014-0126-7, 13:1, Online publication date: 1-Dec-2014.

Hua N, Chen Z, Phinikaridou A, Pham T, Qiao Y, LaValley M, Bigornia S, Ruth M, Apovian C, Ruberg F and Hamilton J (2014) The influence of pericardial fat upon left ventricular function in obese females: evidence of a site-specific effect, Journal of Cardiovascular Magnetic Resonance, 10.1186/1532-429X-16-37, 16:1, Online publication date: 1-Dec-2014.

Lin H, Joehanes R, Pilling L, Dupuis J, Lunetta K, Ying S, Benjamin E, Hernandez D, Singleton A, Melzer D, Munson P, Levy D, Ferrucci L and Murabito J (2014) Whole blood gene expression and interleukin-6 levels, Genomics, 10.1016/j.ygeno.2014.10.003, 104:6, (490-495), Online publication date: 1-Dec-2014.

Pfister R, Michels G, Brägelmann J, Sharp S, Luben R, Wareham N and Khaw K (2014) Plasma vitamin C and risk of hospitalisation with diagnosis of atrial fibrillation in men and women in EPIC-Norfolk prospective study, International Journal of Cardiology, 10.1016/j.ijcard.2014.11.016, 177:3, (830-835), Online publication date: 1-Dec-2014.

Caligiuri S, Aukema H, Ravandi A and Pierce G (2014) Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption, Experimental Gerontology, 10.1016/j.exger.2014.04.005, 59, (51-57), Online publication date: 1-Nov-2014.

Young R, Hopkins R and Agusti A (2014) Statins as adjunct therapy in COPD: how do we cope after STATCOPE?, Thorax, 10.1136/thoraxjnl-2014-205814, 69:10, (891-894), Online publication date: 1-Oct-2014.

Ishizu T (2014) Chronic obstructive pulmonary disease: Pathophysiological impact on heart failure in real clinical situation, Journal of Cardiology, 10.1016/j.jjcc.2014.05.003, 64:4, (250-252), Online publication date: 1-Oct-2014.

Agha G, Loucks E, Tinker L, Waring M, Michaud D, Foraker R, Li W, Martin L, Greenland P, Manson J and Eaton C (2014) Healthy Lifestyle and Decreasing Risk of Heart Failure in Women, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.07.981, 64:17, (1777-1785), Online publication date: 1-Oct-2014.

Lipshultz S, Diamond M, Franco V, Aggarwal S, Leger K, Santos M, Sallan S and Chow E (2014) Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers, Pediatric Drugs, 10.1007/s40272-014-0085-1, 16:5, (373-389), Online publication date: 1-Oct-2014.

Liu M, Chen J, Huang D, Ke J and Wu W (2014) A meta-analysis of proinflammatory cytokines in chronic heart failure, Heart Asia, 10.1136/heartasia-2013-010484, 6:1, (130-136), Online publication date: 8-Sep-2014.

Manhas A, Khanna V, Prakash P, Goyal D, Malasoni R, Naqvi A, Dwivedi A, Dikshit M and Jagavelu K (2014) Curcuma Oil Reduces Endothelial Cell-mediated Inflammation in Postmyocardial Ischemia/Reperfusion in Rats, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000110, 64:3, (228-236), Online publication date: 1-Sep-2014.

Güder G and Rutten F (2014) Comorbidity of Heart Failure and Chronic Obstructive Pulmonary Disease: More than Coincidence, Current Heart Failure Reports, 10.1007/s11897-014-0212-x, 11:3, (337-346), Online publication date: 1-Sep-2014.

Bönner F, Jacoby C, Temme S, Borg N, Ding Z, Schrader J and Flögel U (2014) Multifunctional MR monitoring of the healing process after myocardial infarction, Basic Research in Cardiology, 10.1007/s00395-014-0430-0, 109:5, Online publication date: 1-Sep-2014.

Matsubara J, Sugiyama S, Nozaki T, Akiyama E, Matsuzawa Y, Kurokawa H, Maeda H, Fujisue K, Sugamura K, Yamamoto E, Matsui K, Jinnouchi H and Ogawa H (2014) Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction, Journal of the American Heart Association, 3:4, Online publication date: 15-Aug-2014.

Huang C, Chang C, Kuo C, Huang C, Chiu T, Lin C, Liu C and Guo Y (2014) Serum Iron Concentration, but Not Hemoglobin, Correlates with TIMI Risk Score and 6-Month Left Ventricular Performance after Primary Angioplasty for Acute Myocardial Infarction, PLoS ONE, 10.1371/journal.pone.0104495, 9:8, (e104495)

Sponholtz T, Zhang X, Fontes J, Meigs J, Cupples L, Kiel D, Hannan M and McLean R (2014) Association Between Inflammatory Biomarkers and Bone Mineral Density in a Community‐Based Cohort of Men and Women, Arthritis Care & Research, 10.1002/acr.22270, 66:8, (1233-1240), Online publication date: 1-Aug-2014.

Moughrabi S, Evangelista L, Habib S, Kassabian L, Breen E, Nyamathi A and Irwin M (2013) In Patients With Stable Heart Failure, Soluble TNF-Receptor 2 Is Associated With Increased Risk for Depressive Symptoms, Biological Research For Nursing, 10.1177/1099800413496454, 16:3, (295-302), Online publication date: 1-Jul-2014.

Eisen A, Benderly M, Behar S, Goldbourt U and Haim M (2014) Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease, American Heart Journal, 10.1016/j.ahj.2014.01.008, 167:5, (707-714), Online publication date: 1-May-2014.

Paolini P, Pick D, Lapira J, Sannino G, Pasqualini L, Ludka C, Sprague L, Zhang X, Bartolotta E, Vazquez-Hidalgo E, Barba D, Bazan C and Hardiman G (2014) Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes, Pharmacogenomics, 10.2217/pgs.14.39, 15:6, (759-774), Online publication date: 1-Apr-2014.

Wright K, Crowson C and Gabriel S (2014) Cardiovascular Comorbidity in Rheumatic Diseases, Heart Failure Clinics, 10.1016/j.hfc.2013.10.003, 10:2, (339-352), Online publication date: 1-Apr-2014.

Killeen M, Linder M, Pontoniere P and Crea R (2014) NF-κβ signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities, Drug Discovery Today, 10.1016/j.drudis.2013.11.002, 19:4, (373-378), Online publication date: 1-Apr-2014.

Vaucher J, Marques-Vidal P, Waeber G and Vollenweider P (2014) Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: A population-based study (CoLaus Study), Cytokine, 10.1016/j.cyto.2014.01.003, 66:2, (95-100), Online publication date: 1-Apr-2014.

Liquori M, Christenson R, Collinson P and deFilippi C (2014) Cardiac biomarkers in heart failure, Clinical Biochemistry, 10.1016/j.clinbiochem.2014.01.032, 47:6, (327-337), Online publication date: 1-Apr-2014.

Mostovaya I, Bots M, van den Dorpel M, Goldschmeding R, den Hoedt C, Kamp O, Levesque R, Mazairac A, Penne E, Swinkels D, van der Weerd N, ter Wee P, Nubé M, Blankestijn P, Grooteman M and James L (2014) Left Ventricular Mass in Dialysis Patients, Determinants and Relation with Outcome. Results from the COnvective TRansport STudy (CONTRAST), PLoS ONE, 10.1371/journal.pone.0084587, 9:2, (e84587)

Khan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos A, Georgiopoulou V, Butler J and Laukkanen J (2013) Cardiorespiratory fitness and risk of heart failure: a population‐based follow‐up study, European Journal of Heart Failure, 10.1111/ejhf.37, 16:2, (180-188), Online publication date: 1-Feb-2014.

Park J, Choi D, Yoon C, Oh I, Jeon E, Kim J, Cho M, Chae S, Ryu K, Yoo B, Kang S and Oh B (2014) Prognostic Value of C-Reactive Protein as an Inflammatory and N-Terminal Probrain Natriuretic Peptide as a Neurohumoral Marker in Acute Heart Failure (from the Korean Heart Failure Registry), The American Journal of Cardiology, 10.1016/j.amjcard.2013.10.022, 113:3, (511-517), Online publication date: 1-Feb-2014.

Onoue K, Nakano T and Saito Y (2014) 2. Biomarker, Nihon Naika Gakkai Zasshi, 10.2169/naika.103.345, 103:2, (345-352), .

Miyoshi T and Kitamura K (2014) 8. Distant Organ Dysfunction Associated with AKI, Nihon Naika Gakkai Zasshi, 10.2169/naika.103.1123, 103:5, (1123-1129), .

Marti C, Khan H, Mann D, Georgiopoulou V, Bibbins-Domingo K, Harris T, Koster A, Newman A, Kritchevsky S, Kalogeropoulos A and Butler J (2013) Soluble Tumor Necrosis Factor Receptors and Heart Failure Risk in Older Adults, Circulation: Heart Failure, 7:1, (5-11), Online publication date: 1-Jan-2014.

Schmalgemeier H, Bitter T, Fischbach T, Horstkotte D and Oldenburg O (2013) C-Reactive Protein Is Elevated in Heart Failure Patients with Central Sleep Apnea and Cheyne-Stokes Respiration, Respiration, 10.1159/000351115, 87:2, (113-120), .

Wu J, Xia S, Kalionis B, Wan W and Sun T (2014) The Role of Oxidative Stress and Inflammation in Cardiovascular Aging, BioMed Research International, 10.1155/2014/615312, 2014, (1-13), .

Salazar J, Martínez M, Chávez M, Toledo A, Añez R, Torres Y, Apruzzese V, Silva C, Rojas J and Bermúdez V (2014) C-Reactive Protein: Clinical and Epidemiological Perspectives, Cardiology Research and Practice, 10.1155/2014/605810, 2014, (1-10), .

Chakraborti S, Alam M, Chaudhury A, Sarkar J, Pramanik A, Asrafuzzaman S, Das S, Ghosh S and Chakraborti T (2014) Pathophysiological Aspects of Lipoprotein-Associated Phospholipase A2: A Brief Overview Phospholipases in Health and Disease, 10.1007/978-1-4939-0464-8_7, (115-133), .

Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M and Nourhashemi F (2013) Proinflammatory Cytokines, Aging, and Age-Related Diseases, Journal of the American Medical Directors Association, 10.1016/j.jamda.2013.05.009, 14:12, (877-882), Online publication date: 1-Dec-2013.

LIU J, WU X, LIU Y, XU Y, HUANG Y, XING C and WANG X (2013)(2013) High-glucose-based peritoneal dialysis solution induces the upregulation of VEGF expression in human peritoneal mesothelial cells: The role of pleiotrophin, International Journal of Molecular Medicine, 10.3892/ijmm.2013.1491, 32:5, (1150-1158), Online publication date: 1-Nov-2013.

Karppi J, Kurl S, Mäkikallio T, Ronkainen K and Laukkanen J (2013) Serum β-carotene concentrations and the risk of congestive heart failure in men: A population-based study, International Journal of Cardiology, 10.1016/j.ijcard.2012.12.072, 168:3, (1841-1846), Online publication date: 1-Oct-2013.

Meredith A and McManus B (2013) Vitamin D in Heart Failure, Journal of Cardiac Failure, 10.1016/j.cardfail.2013.09.002, 19:10, (692-711), Online publication date: 1-Oct-2013.

van Diepen S, Vavalle J, Newby L, Clare R, Pieper K, Ezekowitz J, Hochman J, Mahaffey K, Armstrong P and Granger C (2013) The Systemic Inflammatory Response Syndrome in Patients With ST-Segment Elevation Myocardial Infarction*, Critical Care Medicine, 10.1097/CCM.0b013e31828a67b2, 41:9, (2080-2087), Online publication date: 1-Sep-2013.

Zannad F, Stough W, Regnault V, Gheorghiade M, Deliargyris E, Gibson C, Agewall S, Berkowitz S, Burton P, Calvo G, Goldstein S, Verheugt F, Koglin J and O'Connor C (2013) Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges, International Journal of Cardiology, 10.1016/j.ijcard.2012.12.018, 167:5, (1772-1782), Online publication date: 1-Sep-2013.

Hartupee J and Mann D (2013) Positioning of Inflammatory Biomarkers in the Heart Failure Landscape, Journal of Cardiovascular Translational Research, 10.1007/s12265-013-9467-y, 6:4, (485-492), Online publication date: 1-Aug-2013.

Nikolic V, Jevtovic-Stoimenov T, Stokanovic D, Milovanovic M, Velickovic-Radovanovic R, Pesic S, Stoiljkovic M, Pesic G, Ilic S, Deljanin-Ilic M, Marinkovic D, Stefanovic N and Jankovic S (2013) An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure, Journal of Cardiology, 10.1016/j.jjcc.2013.02.013, 62:1, (37-43), Online publication date: 1-Jul-2013.

Sinagra E, Perricone G, Romano C and Cottone M (2013) Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases, European Journal of Internal Medicine, 10.1016/j.ejim.2012.12.015, 24:5, (385-392), Online publication date: 1-Jul-2013.

Cialdella P, Pedicino D, Gustapane M, Santangeli P, Narducci M, Pelargonio G, Basile E, Giglio A, Pazzano V, Vitulano N and Bellocci F (2013) Inflammatory markers in heart failure, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e328349afb6, 14:5, (342-350), Online publication date: 1-May-2013.

Fontes J, Yamamoto J, Larson M, Wang N, Dallmeier D, Rienstra M, Schnabel R, Vasan R, Keaney J and Benjamin E (2013) Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study, Atherosclerosis, 10.1016/j.atherosclerosis.2013.01.019, 228:1, (217-223), Online publication date: 1-May-2013.

Agabiti-Rosei E and Grassi G (2013) Beyond gout: uric acid and cardiovascular diseases, Current Medical Research and Opinion, 10.1185/03007995.2013.790804, 29:sup3, (33-39), Online publication date: 1-Apr-2013.

Nishimoto M, Nakamae H, Koh H, Nakane T, Nakamae M, Hirose A, Hagihara K, Nakao Y, Terada Y, Ohsawa M and Hino M (2012) Risk factors affecting cardiac left-ventricular hypertrophy and systolic and diastolic function in the chronic phase of allogeneic hematopoietic cell transplantation, Bone Marrow Transplantation, 10.1038/bmt.2012.179, 48:4, (581-586), Online publication date: 1-Apr-2013.

Choi E and Lima J (2013) Response to “The prognostic implication of high-sensitivity C-reactive protein in patients with established cardiomyopathy”, American Heart Journal, 10.1016/j.ahj.2013.02.002, 165:4, (e19), Online publication date: 1-Apr-2013.

Rosell J, Nordenskjöld B, Bengtsson N, Fornander T, Hatschek T, Lindman H, Malmström P, Wallgren A, Stål O and Carstensen J (2013) Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up, Breast Cancer Research and Treatment, 10.1007/s10549-013-2457-6, 138:2, (467-473), Online publication date: 1-Apr-2013.

Athilingam P, Moynihan J, Chen L, D’Aoust R, Groer M and Kip K (2012) Elevated Levels of Interleukin 6 and C‐Reactive Protein Associated With Cognitive Impairment in Heart Failure, Congestive Heart Failure, 10.1111/chf.12007, 19:2, (92-98), Online publication date: 1-Mar-2013.

Conen D (2012) Inflammation, blood pressure and cardiovascular disease: heading east, Journal of Human Hypertension, 10.1038/jhh.2012.7, 27:2, (71-71), Online publication date: 1-Feb-2013.

Braunwald E (2013) Heart Failure, JACC: Heart Failure, 10.1016/j.jchf.2012.10.002, 1:1, (1-20), Online publication date: 1-Feb-2013.

Liu M, Zhou M, Bao Y, Xu Z, Li H, Zhang H, Zhu W, Zhang J, Xu A, Wei M and Jia W (2012) Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure, Clinical Science, 10.1042/CS20120004, 124:2, (115-122), Online publication date: 1-Jan-2013.

Karppi J, Laukkanen J, Mäkikallio T, Ronkainen K and Kurl S (2013) Serum β-carotene and the risk of sudden cardiac death in men: A population-based follow-up study, Atherosclerosis, 10.1016/j.atherosclerosis.2012.10.077, 226:1, (172-177), Online publication date: 1-Jan-2013.

Cowie M and Poole-Wilson P (2013) Pathophysiology of Heart Failure Essential Cardiology, 10.1007/978-1-4614-6705-2_18, (327-345), .

Coglianese E, Larson M, Vasan R, Ho J, Ghorbani A, McCabe E, Cheng S, Fradley M, Kretschman D, Gao W, O'Connor G, Wang T and Januzzi J (2012) Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study, Clinical Chemistry, 10.1373/clinchem.2012.192153, 58:12, (1673-1681), Online publication date: 1-Dec-2012.

Martin M and Blaxall B (2012) Cardiac Intercellular Communication: Are Myocytes and Fibroblasts Fair-Weather Friends?, Journal of Cardiovascular Translational Research, 10.1007/s12265-012-9404-5, 5:6, (768-782), Online publication date: 1-Dec-2012.

Jensen L, Kistorp C, Bjerre M, Raymond I and Flyvbjerg A (2011) Plasma calprotectin levels reflect disease severity in patients with chronic heart failure, European Journal of Preventive Cardiology, 10.1177/1741826711421078, 19:5, (999-1004), Online publication date: 1-Oct-2012.

Gandhi S, Narula N, Marshall J and Farkouh M (2012) Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?, The American Journal of Medicine, 10.1016/j.amjmed.2012.03.015, 125:10, (956-962), Online publication date: 1-Oct-2012.

Latini R, Gullestad L, Masson S, Nymo S, Ueland T, Cuccovillo I, Vårdal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P and Tavazzi L (2014) Pentraxin‐3 in chronic heart failure: the CORONA and GISSI‐HF trials, European Journal of Heart Failure, 10.1093/eurjhf/hfs092, 14:9, (992-999), Online publication date: 1-Sep-2012.

McManus D, Lyass A, Ingelsson E, Massaro J, Meigs J, Aragam J, Benjamin E and Vasan R (2012) Relations of Circulating Resistin and Adiponectin and Cardiac Structure and Function: The Framingham Offspring Study, Obesity, 10.1038/oby.2011.32, 20:9, (1882-1886), Online publication date: 1-Sep-2012.

Ikonomidis I, Michalakeas C, Parissis J, Paraskevaidis I, Ntai K, Papadakis I, Anastasiou‐Nana M and Lekakis J (2012) Inflammatory markers in coronary artery disease, BioFactors, 10.1002/biof.1024, 38:5, (320-328), Online publication date: 1-Sep-2012.

YUAN W, GU Y and ZHANG D (2012) Measurement of serum soluble ST2 in patients with heart failure and its diagnostic value, Academic Journal of Second Military Medical University, 10.3724/SP.J.1008.2012.00175, 32:2, (175-178), Online publication date: 14-Aug-2012.

Choi E, Yan R, Fernandes V, Opdahl A, Gomes A, Almeida A, Wu C, Liu K, Carr J, McClelland R, Bluemke D and Lima J (2012) High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: The multiethnic study of atherosclerosis, American Heart Journal, 10.1016/j.ahj.2012.05.010, 164:2, (251-258), Online publication date: 1-Aug-2012.

Grams M and Rabb H (2012) The distant organ effects of acute kidney injury, Kidney International, 10.1038/ki.2011.241, 81:10, (942-948), Online publication date: 1-May-2012.

Battistoni A, Rubattu S and Volpe M (2012) Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases, International Journal of Cardiology, 10.1016/j.ijcard.2011.06.066, 157:2, (160-168), Online publication date: 1-May-2012.

Zorlu A, Akkaya E, Altay H, Bektasoglu G, Turkdogan K, Sincer I, Vuruskan E, Cınar Z, Tandogan I and Yilmaz M (2011) The relationship between D-dimer level and the development of atrial fibrillation in patients with systolic heart failure, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-011-0656-8, 33:4, (343-348), Online publication date: 1-May-2012.

Addison O, LaStayo P, Dibble L and Marcus R (2012) Inflammation, Aging, and Adiposity, Journal of Geriatric Physical Therapy, 10.1519/JPT.0b013e3182312b14, 35:2, (86-94), Online publication date: 1-Apr-2012.

Florea V and Anand I (2012) Biomarkers, Heart Failure Clinics, 10.1016/j.hfc.2011.11.005, 8:2, (207-224), Online publication date: 1-Apr-2012.

Pereira D, Ribeiro-Samora G, Vieira D, Pereira L, Coelho F, Parreira V, Moreira M, Alencar M and Britto R (2011) Evaluation of the Inflammatory Response to Two Different Intensities of Exercise in Individuals with Heart Failure, Inflammation, 10.1007/s10753-011-9339-z, 35:2, (509-515), Online publication date: 1-Apr-2012.

Pfister R, Sharp S, Luben R, Wareham N and Khaw K (2011) Differential white blood cell count and incident heart failure in men and women in the EPIC-Norfolk study, European Heart Journal, 10.1093/eurheartj/ehr457, 33:4, (523-530), Online publication date: 2-Feb-2012.

van Kimmenade R and Januzzi J (2012) Emerging Biomarkers in Heart Failure, Clinical Chemistry, 10.1373/clinchem.2011.165720, 58:1, (127-138), Online publication date: 1-Jan-2012.

Hanna M, Wilson Tang W, Teo B, O’Neill J, Weinstein D, Lau S, Van Lente F, Starling R, Paganini E and Taylor D (2011) Extracorporeal Ultrafiltration vs Conventional Diuretic Therapy in Advanced Decompensated Heart Failure, Congestive Heart Failure, 10.1111/j.1751-7133.2011.00231.x, 18:1, (54-63), Online publication date: 1-Jan-2012.

Bhimaraj A and Tang W (2012) Role of Oxidative Stress in Disease Progression in Stage B, a Pre-cursor of Heart Failure, Heart Failure Clinics, 10.1016/j.hfc.2011.08.003, 8:1, (101-111), Online publication date: 1-Jan-2012.

Kalogeropoulos A, Georgiopoulou V and Butler J (2012) From Risk Factors to Structural Heart Disease: The Role of Inflammation, Heart Failure Clinics, 10.1016/j.hfc.2011.08.002, 8:1, (113-123), Online publication date: 1-Jan-2012.

Martin M, Belmonte S, Ram R, Kamal F and Blaxall B (2012) G-Protein-Coupled Receptors in the Heart Muscle, 10.1016/B978-0-12-381510-1.00008-9, (87-112), .

Ljung L, Simard J, Jacobsson L, Rantapää‐Dahlqvist S and Askling J (2011) Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis, Arthritis & Rheumatism, 10.1002/art.30654, 64:1, (42-52), Online publication date: 1-Jan-2012.

Lüneburg N, Xanthakis V, Schwedhelm E, Sullivan L, Maas R, Anderssohn M, Riederer U, Glazer N, Vasan R and Böger R (2011) Reference Intervals for Plasma L-Arginine and the L-Arginine:Asymmetric Dimethylarginine Ratio in the Framingham Offspring Cohort, The Journal of Nutrition, 10.3945/jn.111.148197, 141:12, (2186-2190), Online publication date: 1-Dec-2011.

Azuaje F, Rodius S, Zhang L, Devaux Y and Wagner D (2011) Information encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarction, BMC Medical Genomics, 10.1186/1755-8794-4-59, 4:1, Online publication date: 1-Dec-2011.

Cheung B, Ong K, Tso A, Leung R, Cherny S, Sham P, Thomas G, Lam T and Lam K (2011) Relationship of Plasma Interleukin-6 and Its Genetic Variants With Hypertension in Hong Kong Chinese, American Journal of Hypertension, 10.1038/ajh.2011.141, 24:12, (1331-1337), Online publication date: 1-Dec-2011.

Amaranto D, Wang E, Eskandari M, Morasch M, Rodriguez H, Pearce W and Kibbe M (2011) Normal preoperative white blood cell count is predictive of outcomes for endovascular procedures, Journal of Vascular Surgery, 10.1016/j.jvs.2011.04.063, 54:5, (1395-1403.e2), Online publication date: 1-Nov-2011.

Sergi G, Sarti S, Mosele M, Ruggiero E, Imoscopi A, Miotto F, Bolzetta F, Inelmen E, Manzato E and Coin A (2011) Changes in healthy elderly women's physical performance: A 3-year follow-up, Experimental Gerontology, 10.1016/j.exger.2011.08.008, 46:11, (929-933), Online publication date: 1-Nov-2011.

Liu Q, Tu T, Bai Z and Zhou S (2011) Pentraxin 3 as a new biomarker of diastolic dysfunction, International Journal of Cardiology, 10.1016/j.ijcard.2011.07.011, 152:1, (106-107), Online publication date: 1-Oct-2011.

Funayama A, Shishido T, Netsu S, Ishino M, Sasaki T, Katoh S, Takahashi H, Arimoto T, Miyamoto T, Nitobe J, Watanabe T and Kubota I (2011) Serum Pregnancy-Associated Plasma Protein A in Patients With Heart Failure, Journal of Cardiac Failure, 10.1016/j.cardfail.2011.05.011, 17:10, (819-826), Online publication date: 1-Oct-2011.

Bekwelem W, Lutsey P, Loehr L, Agarwal S, Astor B, Guild C, Ballantyne C and Folsom A (2011) White Blood Cell Count, C-Reactive Protein, and Incident Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study, Annals of Epidemiology, 10.1016/j.annepidem.2011.06.005, 21:10, (739-748), Online publication date: 1-Oct-2011.

Wang X, Takagawa J, Lam V, Haddad D, Tobler D, Mok P, Zhang Y, Clifford B, Pinnamaneni K, Saini S, Su R, Bartel M, Sievers R, Carbone L, Kogan S, Yeghiazarians Y, Hermiston M and Springer M (2011) Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1–Mediated Inflammatory Response, Science Translational Medicine, 10.1126/scitranslmed.3002814, 3:100, Online publication date: 14-Sep-2011.

Smit L, Katan M, Wanders A and Basu S (2011) A High Intake of trans Fatty Acids Has Little Effect on Markers of Inflammation and Oxidative Stress in Humans, The Journal of Nutrition, 10.3945/jn.110.134668, 141:9, (1673-1678), Online publication date: 1-Sep-2011.

Ketchum E and Levy W (2011) Establishing Prognosis in Heart Failure: A Multimarker Approach, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2011.03.003, 54:2, (86-96), Online publication date: 1-Sep-2011.

Fan Y, Weng Y, Huebler M, Cowger J, Morales D, Franz N, Xiao Y, Potapov E and Hetzer R (2011) Predictors of In-Hospital Mortality in Children After Long-Term Ventricular Assist Device Insertion, Journal of the American College of Cardiology, 10.1016/j.jacc.2011.06.017, 58:11, (1183-1190), Online publication date: 1-Sep-2011.

Wilkinson J, Diamond M and Miller T (2011) The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults, Progress in Pediatric Cardiology, 10.1016/j.ppedcard.2011.06.006, 32:1, (25-34), Online publication date: 1-Aug-2011.

Kantor P, Rusconi P, Lipshultz S, Mital S, Wilkinson J and Burch M (2011) Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the Second International Conference on Pediatric Cardiomyopathy, Progress in Pediatric Cardiology, 10.1016/j.ppedcard.2011.06.003, 32:1, (11-14), Online publication date: 1-Aug-2011.

Chow S, O'Barr S, Peng J, Chew E, Pak F, Quist R, Patel P, Patterson J and Heywood J (2011) Modulation of Novel Cardiorenal and Inflammatory Biomarkers by Intravenous Nitroglycerin and Nesiritide in Acute Decompensated Heart Failure, Circulation: Heart Failure, 4:4, (450-455), Online publication date: 1-Jul-2011.

Giannessi D (2011) Multimarker approach for heart failure management: Perspectives and limitations, Pharmacological Research, 10.1016/j.phrs.2011.03.006, 64:1, (11-24), Online publication date: 1-Jul-2011.

Singh T and Newman A (2011) Inflammatory markers in population studies of aging, Ageing Research Reviews, 10.1016/j.arr.2010.11.002, 10:3, (319-329), Online publication date: 1-Jul-2011.

Tsushima K, Osawa T, Yanai H, Nakajima A, Takaoka A, Manabe I, Ohba Y, Imai Y, Taniguchi T and Nagai R (2011) IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II‐induced hypertension, The FASEB Journal, 10.1096/fj.10-174615, 25:5, (1531-1543), Online publication date: 1-May-2011.

Kaess B and Vasan R (2011) Pentraxin 3—a marker of diastolic dysfunction and HF?, Nature Reviews Cardiology, 10.1038/nrcardio.2011.50, 8:5, (246-248), Online publication date: 1-May-2011.

Van Lieshout M, Verwoert G, Mattace-Raso F, Zillikens M, Sijbrands E, Deckers J, Hofman A and Witteman J (2010) Measures of body composition and risk of heart failure in the elderly: The Rotterdam study, The journal of nutrition, health & aging, 10.1007/s12603-010-0288-2, 15:5, (393-397), Online publication date: 1-May-2011.

Greig D, Alcaino H, Castro P, Garcia L, Verdejo H, Navarro M, López R, Mellado R, Tapia F, Gabrielli L, Nogerol C, Chiong M, Godoy I and Lavandero S (2011) Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters, The Journal of Heart and Lung Transplantation, 10.1016/j.healun.2010.10.003, 30:4, (408-413), Online publication date: 1-Apr-2011.

Aguilar J (2011) La insuficiencia cardíaca en el siglo XXI. Epidemiología y consecuencias económicas, Cirugía Cardiovascular, 10.1016/S1134-0096(11)70062-6, 18:2, (83-89), Online publication date: 1-Apr-2011.

Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, Matsuzawa Y, Akiyama E, Yamamoto E, Sakamoto K, Nagayoshi Y, Kaikita K, Sumida H, Kim-Mitsuyama S and Ogawa H (2011) Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction, Journal of the American College of Cardiology, 10.1016/j.jacc.2010.10.018, 57:7, (861-869), Online publication date: 1-Feb-2011.

Zhang L, Zhang S, Jiang H, Sun A, Zou Y and Ge J (2010) Effects of Statin Treatment on Cardiac Function in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials, Clinical Cardiology, 10.1002/clc.20821, 34:2, (117-123), Online publication date: 1-Feb-2011.

Brandt E (2011) Deception of Trans Fats on Food and Drug Administration Food Labels: A Proposed Revision to the Presentation of Trans Fats on Food Labels, American Journal of Health Promotion, 10.4278/ajhp.100603-CIT-174, 25:3, (157-158), Online publication date: 1-Jan-2011.

Kantor P and Rusconi P (2011) Biomarkers in pediatric heart failure: Their role in diagnosis and evaluating disease progression, Progress in Pediatric Cardiology, 10.1016/j.ppedcard.2010.11.012, 31:1, (53-57), Online publication date: 1-Jan-2011.

Georgiopoulou V, Kalogeropoulos A, Sperling L and Butler J (2011) Heart Failure Prevention Preventive Cardiology: Companion to Braunwald's Heart Disease, 10.1016/B978-1-4377-1366-4.00010-X, (141-160), .

Slavin L, Daniels L and Maisel A (2011) The Use of Biomarkers in the Evaluation of Heart Failure Heart Failure: A Companion to Braunwald's Heart Disease, 10.1016/B978-1-4160-5895-3.10037-3, (545-559), .

Velagaleti R and Vasan R (2011) Epidemiology of Heart Failure Heart Failure: A Companion to Braunwald's Heart Disease, 10.1016/B978-1-4160-5895-3.10022-1, (346-354), .

Jha S and Kitsis R (2011) Myocardial Basis for Heart Failure Heart Failure: A Companion to Braunwald's Heart Disease, 10.1016/B978-1-4160-5895-3.10006-3, (85-102), .

Kleinbongard P, Schulz R and Heusch G (2010) TNFα in myocardial ischemia/reperfusion, remodeling and heart failure, Heart Failure Reviews, 10.1007/s10741-010-9180-8, 16:1, (49-69), Online publication date: 1-Jan-2011.

Архипов В (2010) Хроническая обструктивная болезнь легких и хроническая сердечная недостаточность: особенности совместной терапии, PULMONOLOGIYA, 10.18093/0869-0189-2010-6-120-127:6, (120-127)

Carson J and Adamson J (2010) Iron Deficiency and Heart Disease: Ironclad Evidence?, Hematology, 10.1182/asheducation-2010.1.348, 2010:1, (348-350), Online publication date: 4-Dec-2010.

Alehagen U, Dahlström U, Rehfeld J and Goetze J (2010) Prognostic Assessment of Elderly Patients with Symptoms of Heart Failure by Combining High-Sensitivity Troponin T and N-Terminal Pro–B-Type Natriuretic Peptide Measurements, Clinical Chemistry, 10.1373/clinchem.2009.141341, 56:11, (1718-1724), Online publication date: 1-Nov-2010.

Wang Y and Hu G (2010) Individual and Joint Associations of Obesity and Physical Activity on the Risk of Heart Failure, Congestive Heart Failure, 10.1111/j.1751-7133.2010.00189.x, 16:6, (292-299), Online publication date: 1-Nov-2010.

Bilim O, Takeishi Y, Kitahara T, Ishino M, Sasaki T, Suzuki S, Shishido T and Kubota I (2010) Serum YKL-40 Predicts Adverse Clinical Outcomes in Patients With Chronic Heart Failure, Journal of Cardiac Failure, 10.1016/j.cardfail.2010.05.029, 16:11, (873-879), Online publication date: 1-Nov-2010.

Micha R and Mozaffarian D (2010) Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the Evidence, Lipids, 10.1007/s11745-010-3393-4, 45:10, (893-905), Online publication date: 1-Oct-2010.

McLean A and Huang S (2010) Biomarkers of Cardiac Injury Biomarkers, 10.1002/9780470918562.ch7, (119-155), Online publication date: 20-Sep-2010.

da Silva C, Fattori A, Sousa A, Mazon S, Alegre S, Almeida E and Guariento M (2010) Determinación de la concentración plasmática de proteína C reactiva en pacientes con diferentes formas clínicas de la enfermedad de Chagas, Revista Española de Cardiología, 10.1016/S0300-8932(10)70233-5, 63:9, (1096-1099), Online publication date: 1-Sep-2010.

Kurt İ, Yavuzer K and Batur M (2010) Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure, Heart and Vessels, 10.1007/s00380-009-1216-4, 25:5, (392-399), Online publication date: 1-Sep-2010.

Sakthivel P, Wermeling F, Elmgren A, Hulthe J, Kakoulidou M, Kari Lefvert A and Lind L (2010) Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population, Scandinavian Journal of Clinical and Laboratory Investigation, 10.3109/00365511003695608, 70:4, (237-243), Online publication date: 1-Jul-2010.

Booth A and Bishop D (2010) TGF-β, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection, Immunotherapy, 10.2217/imt.10.33, 2:4, (511-520), Online publication date: 1-Jul-2010.

Szabo-Fresnais N, Lefebvre F, Germain A, Fischmeister R and Pomérance M (2010) A new regulation of IL-6 production in adult cardiomyocytes by β-adrenergic and IL-1β receptors and induction of cellular hypertrophy by IL-6 trans-signalling, Cellular Signalling, 10.1016/j.cellsig.2010.03.009, 22:7, (1143-1152), Online publication date: 1-Jul-2010.

Bozkurt B, Mann D and Deswal A (2009) Biomarkers of inflammation in heart failure, Heart Failure Reviews, 10.1007/s10741-009-9140-3, 15:4, (331-341), Online publication date: 1-Jul-2010.

Rocchiccioli J, McMurray J and Dominiczak A (2008) Biomarkers in heart failure: a clinical review, Heart Failure Reviews, 10.1007/s10741-008-9123-9, 15:4, (251-273), Online publication date: 1-Jul-2010.

de Couto G, Ouzounian M and Liu P (2010) Early detection of myocardial dysfunction and heart failure, Nature Reviews Cardiology, 10.1038/nrcardio.2010.51, 7:6, (334-344), Online publication date: 1-Jun-2010.

Beavers K, Brinkley T and Nicklas B (2010) Effect of exercise training on chronic inflammation, Clinica Chimica Acta, 10.1016/j.cca.2010.02.069, 411:11-12, (785-793), Online publication date: 1-Jun-2010.

Kalogeropoulos A, Georgiopoulou V, Psaty B, Rodondi N, Smith A, Harrison D, Liu Y, Hoffmann U, Bauer D, Newman A, Kritchevsky S, Harris T and Butler J (2010) Inflammatory Markers and Incident Heart Failure Risk in Older Adults, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.12.045, 55:19, (2129-2137), Online publication date: 1-May-2010.

Friedman E and Herd P (2010) Income, Education, and Inflammation: Differential Associations in a National Probability Sample (The MIDUS Study), Psychosomatic Medicine, 10.1097/PSY.0b013e3181cfe4c2, 72:3, (290-300), Online publication date: 1-Apr-2010.

Tamariz L and Hare J (2010) Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers, European Heart Journal, 10.1093/eurheartj/ehq014, 31:7, (768-770), Online publication date: 1-Apr-2010.

Yan A, Yan R, Cushman M, Redheuil A, Tracy R, Arnett D, Rosen B, McClelland R, Bluemke D and Lima J (2010) Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis, European Heart Journal, 10.1093/eurheartj/ehp454, 31:7, (875-882), Online publication date: 1-Apr-2010.

Kühne M and Conen D (2010) Atrial fibrillation in women, Therapy, 10.2217/thy.10.11, 7:2, (139-146), Online publication date: 1-Mar-2010.

Vistnes M, Christensen G and Omland T (2014) Multiple cytokine biomarkers in heart failure, Expert Review of Molecular Diagnostics, 10.1586/erm.10.3, 10:2, (147-157), Online publication date: 1-Mar-2010.

Liebson P (2010) ARBITER-6 HALTS and Lipid Concentrations and Heart Failure Incidence: Framingham Heart Study, Preventive Cardiology, 10.1111/j.1751-7141.2010.00069.x, Online publication date: 1-Mar-2010.

Adlbrecht C, Distelmaier K, Bonderman D, Beran G, Redwan B, Strunk G, Binder T, Jakowitsch J, Probst P, Heinze G, Maurer G and Lang I (2010) Long‐term outcome after thrombectomy in acute myocardial infarction, European Journal of Clinical Investigation, 10.1111/j.1365-2362.2009.02253.x, 40:3, (233-241), Online publication date: 1-Mar-2010.

Barreto D, Barreto F, Liabeuf S, Temmar M, Lemke H, Tribouilloy C, Choukroun G, Vanholder R and Massy Z (2010) Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease, Kidney International, 10.1038/ki.2009.503, 77:6, (550-556), Online publication date: 1-Mar-2010.

Hunter J, Zhang J and Kris-Etherton P (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review, The American Journal of Clinical Nutrition, 10.3945/ajcn.2009.27661, 91:1, (46-63), Online publication date: 1-Jan-2010.

Biswas S, Ghoshal P, Mandal S and Mandal N (2010) Relation of Anti- to Pro-Inflammatory Cytokine Ratios with Acute Myocardial Infarction, The Korean Journal of Internal Medicine, 10.3904/kjim.2010.25.1.44, 25:1, (44), .

Koyama T, Watanabe H, Kobukai Y, Makabe S, Munehisa Y, Iino K, Kosaka T and Ito H (2010) Beneficial Effects of Adaptive Servo Ventilation in Patients With Chronic Heart Failure, Circulation Journal, 10.1253/circj.CJ-10-0082, 74:10, (2118-2124), .

Rehkopf D, Krieger N, Coull B and Berkman L (2010) Biologic Risk Markers for Coronary Heart Disease, Epidemiology, 10.1097/EDE.0b013e3181c30b89, 21:1, (38-46), Online publication date: 1-Jan-2010.

Horwich T and Fonarow G (2010) Glucose, Obesity, Metabolic Syndrome, and Diabetes, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.07.029, 55:4, (283-293), Online publication date: 1-Jan-2010.

Romeo R, Scalisi C, Tafuri L, Romeo A, Maugeri D and Sorace R (2010) Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics, Archives of Gerontology and Geriatrics, 10.1016/j.archger.2009.02.008, 50:1, (101-104), Online publication date: 1-Jan-2010.

da Silva C, Fattori A, Sousa A, Mazon S, Alegre S, Almeida E and Guariento M (2010) Determining the C-Reactive Protein Level in Patients With Different Clinical Forms of Chagas Disease, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(10)70215-2, 63:9, (1096-1099), Online publication date: 1-Jan-2010.

Scully R, Miller A, Grant Y and Lipshultz S (2010) Anthracycline, Herceptin, and CV Toxicity Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00726-0, (413-427), .

Friedman E (2010) Stress and Immune Functions* Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00631-X, (531-547), .

Estévez-Loureiro R, Recio-Mayoral A, Sieira-Rodríguez-Moret J, Trallero-Araguás E and Kaski J (2009) Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris, Atherosclerosis, 10.1016/j.atherosclerosis.2009.04.032, 207:2, (514-518), Online publication date: 1-Dec-2009.

Schaap L, Pluijm S, Deeg D, Harris T, Kritchevsky S, Newman A, Colbert L, Pahor M, Rubin S, Tylavsky F and Visser M (2009) Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 10.1093/gerona/glp097, 64A:11, (1183-1189), Online publication date: 1-Nov-2009.

Holme I, Aastveit A, Hammar N, Jungner I and Walldius G (2009) Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS), European Journal of Heart Failure, 10.1093/eurjhf/hfp129, 11:11, (1036-1042), Online publication date: 1-Nov-2009.

Sattelmair J, Pertman J and Forman D (2009) Effects of Physical Activity on Cardiovascular and Noncardiovascular Outcomes in Older Adults, Clinics in Geriatric Medicine, 10.1016/j.cger.2009.07.004, 25:4, (677-702), Online publication date: 1-Nov-2009.

Tang W (2009) Biomarkers of risk stratification in congestive heart failure: North American view, Biomarkers in Medicine, 10.2217/bmm.09.52, 3:5, (443-452), Online publication date: 1-Oct-2009.

Engström G, Melander O and Hedblad B (2009) Carotid Intima-Media Thickness, Systemic Inflammation, and Incidence of Heart Failure Hospitalizations, Arteriosclerosis, Thrombosis, and Vascular Biology, 29:10, (1691-1695), Online publication date: 1-Oct-2009.

Richards A (2009) What We May Expect from Biomarkers in Heart Failure, Heart Failure Clinics, 10.1016/j.hfc.2009.04.011, 5:4, (463-470), Online publication date: 1-Oct-2009.

Puiggròs C, Sánchez J, Chacón P, Sabín P, Roselló J, Bou R and Planas M (2009) Evolution of Lipid Profile, Liver Function, and Pattern of Plasma Fatty Acids According to the Type of Lipid Emulsion Administered in Parenteral Nutrition in the Early Postoperative Period After Digestive Surgery, Journal of Parenteral and Enteral Nutrition, 10.1177/0148607109333001, 33:5, (501-512), Online publication date: 1-Sep-2009.

Suzuki T, Solomon C, Jenny N, Tracy R, Nelson J, Psaty B, Furberg C and Cushman M (2009) Lipoprotein-Associated Phospholipase A2 and Risk of Congestive Heart Failure in Older Adults, Circulation: Heart Failure, 2:5, (429-436), Online publication date: 1-Sep-2009.

Zhu S, Patel K, Bandinelli S, Ferrucci L and Guralnik J (2009) Predictors of Interleukin‐6 Elevation in Older Adults, Journal of the American Geriatrics Society, 10.1111/j.1532-5415.2009.02426.x, 57:9, (1672-1677), Online publication date: 1-Sep-2009.

Abou-Raya S and Abou-Raya A (2009) Osteoporosis and congestive heart failure (CHF) in the elderly patient: Double disease burden, Archives of Gerontology and Geriatrics, 10.1016/j.archger.2008.09.004, 49:2, (250-254), Online publication date: 1-Sep-2009.

Schwedhelm E, Xanthakis V, Maas R, Sullivan L, Schulze F, Riederer U, Benndorf R, Böger R and Vasan R (2009) Asymmetric Dimethylarginine Reference Intervals Determined with Liquid Chromatography–Tandem Mass Spectrometry: Results from the Framingham Offspring Cohort, Clinical Chemistry, 10.1373/clinchem.2009.124263, 55:8, (1539-1545), Online publication date: 1-Aug-2009.

Diaz J, Booth A, Lu G, Wood S, Pinsky D and Bishop D (2009) Critical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft Rejection, American Journal of Transplantation, 10.1111/j.1600-6143.2009.02706.x, 9:8, (1773-1783), Online publication date: 1-Aug-2009.

Butler J, Kalogeropoulos A, Georgiopoulou V, de Rekeneire N, Rodondi N, Smith A, Hoffmann U, Kanaya A, Newman A, Kritchevsky S, Vasan R, Wilson P and Harris T (2009) Serum Resistin Concentrations and Risk of New Onset Heart Failure in Older Persons, Arteriosclerosis, Thrombosis, and Vascular Biology, 29:7, (1144-1149), Online publication date: 1-Jul-2009.

Shin M, Lee K, Chung J, Park Y, Choi M, Oh J, Choi J, Lee S, Chung N and Kang S (2009) Circulating IL-8 levels in heart failure patients with and without metabolic syndrome, Clinica Chimica Acta, 10.1016/j.cca.2009.04.020, 405:1-2, (139-142), Online publication date: 1-Jul-2009.

Arroyo-Espliguero R, Avanzas P, Quiles J and Kaski J (2009) C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina, Atherosclerosis, 10.1016/j.atherosclerosis.2008.12.018, 205:1, (319-324), Online publication date: 1-Jul-2009.

Celik T, Iyisoy A, Celik M, Yuksel U and Isik E (2009) Muscle wastage in heart failure: Orphan of the heart failure, International Journal of Cardiology, 10.1016/j.ijcard.2007.12.121, 135:2, (233-236), Online publication date: 1-Jun-2009.

Engström G, Melander O and Hedblad B (2009) Leukocyte Count and Incidence of Hospitalizations Due to Heart Failure, Circulation: Heart Failure, 2:3, (217-222), Online publication date: 1-May-2009.

Tang W, Katz R, Brennan M, Aviles R, Tracy R, Psaty B and Hazen S (2009) Usefulness of Myeloperoxidase Levels in Healthy Elderly Subjects to Predict Risk of Developing Heart Failure, The American Journal of Cardiology, 10.1016/j.amjcard.2009.01.026, 103:9, (1269-1274), Online publication date: 1-May-2009.

Kamiński K, Kożuch M, Bonda T, Stepaniuk M, Waszkiewicz E, Chyczewski L, Musiał W and Winnicka M (2009) Effect of interleukin 6 deficiency on the expression of Bcl-2 and Bax in the murine heart, Pharmacological Reports, 10.1016/S1734-1140(09)70093-3, 61:3, (504-513), Online publication date: 1-May-2009.

CHAWLA L and KRISHNAN M (2009) Causes and consequences of inflammation on anemia management in hemodialysis patients, Hemodialysis International, 10.1111/j.1542-4758.2009.00352.x, 13:2, (222-234), Online publication date: 1-Apr-2009.

Vivo R, Krim S, Cevik C and Witteles R (2009) Heart Failure in Hispanics, Journal of the American College of Cardiology, 10.1016/j.jacc.2008.12.037, 53:14, (1167-1175), Online publication date: 1-Apr-2009.

Araújo J, Lourenço P, Azevedo A, Friões F, Rocha-Gonçalves F, Ferreira A and Bettencourt P (2009) Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review, Journal of Cardiac Failure, 10.1016/j.cardfail.2008.10.030, 15:3, (256-266), Online publication date: 1-Apr-2009.

Gerber Y, Dunlay S, Jaffe A, McConnell J, Weston S, Killian J and Roger V (2009) Plasma lipoprotein-associated phospholipase A2 levels in heart failure: Association with mortality in the community, Atherosclerosis, 10.1016/j.atherosclerosis.2008.07.035, 203:2, (593-598), Online publication date: 1-Apr-2009.

Zandbergen H, Sharma U, Gupta S, Verjans J, van den Borne S, Pokharel S, van Brakel T, Duijvestijn A, van Rooijen N, Maessen J, Reutelingsperger C, Pinto Y, Narula J and Hofstra L (2009) Macrophage Depletion in Hypertensive Rats Accelerates Development of Cardiomyopathy, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248408329860, 14:1, (68-75), Online publication date: 1-Mar-2009.

Sadek M, Haddad T and Haddad H (2009) The role of statins in chronic heart failure, Current Opinion in Cardiology, 10.1097/HCO.0b013e3283229afb, 24:2, (167-171), Online publication date: 1-Mar-2009.

Frankel D, Vasan R, D'Agostino R, Benjamin E, Levy D, Wang T and Meigs J (2009) Resistin, Adiponectin, and Risk of Heart Failure, Journal of the American College of Cardiology, 10.1016/j.jacc.2008.07.073, 53:9, (754-762), Online publication date: 1-Mar-2009.

Scirica B, Cannon C, Sabatine M, Jarolim P, Sloane S, Rifai N, Braunwald E and Morrow D (2009) Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death, Clinical Chemistry, 10.1373/clinchem.2008.117192, 55:2, (265-273), Online publication date: 1-Feb-2009.

Hawkins N, Petrie M, Jhund P, Chalmers G, Dunn F and McMurray J (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology, European Journal of Heart Failure, 10.1093/eurjhf/hfn013, 11:2, (130-139), Online publication date: 1-Feb-2009.

Engström G, Hedblad B, Tydén P and Lindgärde F (2009) Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: A population-based cohort study, Atherosclerosis, 10.1016/j.atherosclerosis.2008.05.038, 202:2, (617-622), Online publication date: 1-Feb-2009.

Okada K, Kurita A, Takase B, Otsuka T, Kodani E, Kusama Y, Atarashi H and Mizuno K (2009) Effects of Music Therapy on Autonomic Nervous System Activity, Incidence of Heart Failure Events, and Plasma Cytokine and Catecholamine Levels in Elderly Patients With Cerebrovascular Disease and Dementia, International Heart Journal, 10.1536/ihj.50.95, 50:1, (95-110), .

Meguro T, Nagatomo Y, Nagae A, Seki C, Kondou N, Shibata M and Oda Y (2009) Elevated Arterial Stiffness Evaluated by Brachial-Ankle Pulse Wave Velocity is Deleterious for the Prognosis of Patients With Heart Failure, Circulation Journal, 10.1253/circj.CJ-08-0350, 73:4, (673-680), .

Loehr L, Rosamond W, Poole C, Marie McNeill A, Chang P, Folsom A, Chambless L and Heiss G (2009) Association of Multiple Anthropometrics of Overweight and Obesity With Incident Heart Failure, Circulation: Heart Failure, 2:1, (18-24), Online publication date: 1-Jan-2009.

Aggelopoulos P, Chrysohoou C, Pitsavos C, Papadimitriou L, Liontou C, Panagiotakos D, Tsiamis E and Stefanadis C (2009) Comparative Value of Simple Inflammatory Markers in the Prediction of Left Ventricular Systolic Dysfunction in Postacute Coronary Syndrome Patients, Mediators of Inflammation, 10.1155/2009/826297, 2009, (1-7), .

Sundstrom J, Ingelsson E, Berglund L, Zethelius B, Lind L, Venge P and Arnlov J (2008) Cardiac troponin-I and risk of heart failure: a community-based cohort study, European Heart Journal, 10.1093/eurheartj/ehp047, 30:7, (773-781)

Kiczak L, Paslawska U, Bania J, Ugorski M, Sambor I, Kochman A, Blach J and Chelmonska-Soyta A (2008) Increased expression of interleukin-1β and its novel splice variant in canine hearts with volume overload, Cytokine, 10.1016/j.cyto.2008.10.002, 44:3, (352-360), Online publication date: 1-Dec-2008.

Brunetti N, Pellegrino P, Correale M, De Gennaro L, Cuculo A and Di Biase M (2007) Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-007-0088-7, 26:3, (196-202), Online publication date: 1-Dec-2008.

Von Bibra H, Diamant M, Scheffer P, Siegmund T and Schumm-Draeger P (2008) Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease, Diabetes and Vascular Disease Research, 10.3132/dvdr.2008.045, 5:4, (310-318), Online publication date: 1-Nov-2008.

Suzuki T, Katz R, Jenny N, Zakai N, LeWinter M, Barzilay J and Cushman M (2008) Metabolic Syndrome, Inflammation, and Incident Heart Failure in the Elderly, Circulation: Heart Failure, 1:4, (242-248), Online publication date: 1-Nov-2008.

Artz A, Wickrema A, Dinner S, Godley L, Kocherginsky M, Odenike O, Rich E, Stock W, Ulaszek J, Larson R and van Besien K (2008) Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation, 10.1016/j.bbmt.2008.08.004, 14:11, (1209-1216), Online publication date: 1-Nov-2008.

Wilson P (2008) Evidence of Systemic Inflammation and Estimation of Coronary Artery Disease Risk: A Population Perspective, The American Journal of Medicine, 10.1016/j.amjmed.2008.06.012, 121:10, (S15-S20), Online publication date: 1-Oct-2008.

Micha R and Mozaffarian D (2008) Trans fatty acids: Effects on cardiometabolic health and implications for policy, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2008.09.008, 79:3-5, (147-152), Online publication date: 1-Sep-2008.

Niethammer M, Sieber M, von Haehling S, Anker S, Munzel T, Horstick G and Genth-Zotz S (2008) Inflammatory pathways in patients with heart failure and preserved ejection fraction, International Journal of Cardiology, 10.1016/j.ijcard.2007.05.061, 129:1, (111-117), Online publication date: 1-Sep-2008.

Mazzola A, Cianti R, Bini L, Armini A, Eberini I, Pompella G, Capecchi P, Natale M, Abbracchio M and Laghi‐Pasini F (2014) Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure, European Journal of Heart Failure, 10.1016/j.ejheart.2008.06.003, 10:8, (749-757), Online publication date: 1-Aug-2008.

Radauceanu A, Ducki C, Virion J, Rossignol P, Mallat Z, McMurray J, Van Veldhuisen D, Tavazzi L, Mann D, Capiaumont-Vin J, Li M, Hanriot D and Zannad F (2008) Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure, Journal of Cardiac Failure, 10.1016/j.cardfail.2008.02.014, 14:6, (467-474), Online publication date: 1-Aug-2008.

Denollet J, Vrints C and Conraads V (2008) Comparing Type D personality and older age as correlates of tumor necrosis factor-α dysregulation in chronic heart failure, Brain, Behavior, and Immunity, 10.1016/j.bbi.2007.10.015, 22:5, (736-743), Online publication date: 1-Jul-2008.

Herndon C, Hutchison R, Berdine H, Stacy Z, Chen J, Farnsworth D, Dang D and Fermo J (2012) Management of Chronic Nonmalignant Pain with Nonsteroidal Antiinflammatory Drugs, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1592/phco.28.6.788, 28:6, (788-805), Online publication date: 1-Jun-2008.

Lavi S, Herrmann J, Lavi R, McConnell J, Lerman L and Lerman A (2008) Role of lipoprotein-associated phospholipase A2 in atherosclerosis, Current Atherosclerosis Reports, 10.1007/s11883-008-0036-9, 10:3, (230-235), Online publication date: 1-Jun-2008.

Braunwald E (2008) Biomarkers in Heart Failure, New England Journal of Medicine, 10.1056/NEJMra0800239, 358:20, (2148-2159), Online publication date: 15-May-2008.

Yeh S, Blackwood K and Schuster M (2008) The Cytokine Basis of Cachexia and its Treatment: Are They Ready for Prime Time?, Journal of the American Medical Directors Association, 10.1016/j.jamda.2008.01.003, 9:4, (219-236), Online publication date: 1-May-2008.

Bahrami H, Bluemke D, Kronmal R, Bertoni A, Lloyd-Jones D, Shahar E, Szklo M and Lima J (2008) Novel Metabolic Risk Factors for Incident Heart Failure and Their Relationship With Obesity, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.12.048, 51:18, (1775-1783), Online publication date: 1-May-2008.

Gallicchio L, Chang H, Christo D, Thuita L, Huang H, Strickland P, Ruczinski I, Hoffman S and Helzlsouer K (2008) Single Nucleotide Polymorphisms in Inflammation-related Genes and Mortality in a Community-based Cohort in Washington County, Maryland, American Journal of Epidemiology, 10.1093/aje/kwm378, 167:7, (807-813), Online publication date: 1-Apr-2008., Online publication date: 1-Apr-2008.

Michowitz Y, Arbel Y, Wexler D, Sheps D, Rogowski O, Shapira I, Berliner S, Keren G, George J and Roth A (2008) Predictive value of high sensitivity CRP in patients with diastolic heart failure, International Journal of Cardiology, 10.1016/j.ijcard.2007.02.037, 125:3, (347-351), Online publication date: 1-Apr-2008.

Wislowska M, Jaszczyk B, Kochmański M, Sypuła S and Sztechman M (2007) Diastolic heart function in RA patients, Rheumatology International, 10.1007/s00296-007-0473-8, 28:6, (513-519), Online publication date: 1-Apr-2008.

Nonaka‐Sarukawa M, Okada T, Ito T, Yamamoto K, Yoshioka T, Nomoto T, Hojo Y, Shimpo M, Urabe M, Mizukami H, Kume A, Ikeda U, Shimada K and Ozawa K (2008) Adeno‐associated virus vector‐mediated systemic interleukin‐10 expression ameliorates hypertensive organ damage in Dahl salt‐sensitive rats, The Journal of Gene Medicine, 10.1002/jgm.1166, 10:4, (368-374), Online publication date: 1-Apr-2008.

Tsao T, Lai J, Yang S, Ho L, Liou J, Cheng C and Cheng S (2008) Suppression of tissue necrosis factor-alpha or hydrogen peroxide-activated primary human T lymphocytes by Ginkgo biloba extract through down-regulation of activator protein-1 signal transduction, Phytomedicine, 10.1016/j.phymed.2007.03.016, 15:3, (170-176), Online publication date: 1-Mar-2008.

Kim Y, Shin Y, Bae J, Lee J, Ham J, Son Y, Kim J, Kim C, Lee B, Oh J, Othman T, Min Y and Yang H (2007) Beneficial effects of cardiac rehabilitation and exercise after percutaneous coronary intervention on hsCRP and inflammatory cytokines in CAD patients, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-007-0356-6, 455:6, (1081-1088), Online publication date: 1-Mar-2008.

El-Menyar A (2008) Cytokines and Myocardial Dysfunction: State of the Art, Journal of Cardiac Failure, 10.1016/j.cardfail.2007.09.006, 14:1, (61-74), Online publication date: 1-Feb-2008.

Rashidi F, Rashidi A, Golmohamadi A, Hoseinzadeh E, Mohammadi B, Mirzajani H, Kheiri M and Jamshidi P (2008) Does Absolute Neutrophilia Predict Early Congestive Heart Failure After Acute Myocardial Infarction? A Cross-Sectional Study, Southern Medical Journal, 10.1097/SMJ.0b013e31815d3e11, 101:1, (19-23), Online publication date: 1-Jan-2008.

Guigoz Y, Doré J and Schiffrin E (2008) The inflammatory status of old age can be nurtured from the intestinal environment, Current Opinion in Clinical Nutrition and Metabolic Care, 10.1097/MCO.0b013e3282f2bfdf, 11:1, (13-20), Online publication date: 1-Jan-2008.

Vila V, Sales V, Almenar L, Lázaro I, Villa P and Reganon E (2008) Effect of oral anticoagulant therapy on thrombospondin-1 and von Willebrand factor in patients with stable heart failure, Thrombosis Research, 10.1016/j.thromres.2007.06.011, 121:5, (611-615), .

Williams E, Shah S, Ali S, Na B, Schiller N and Whooley M (2014) C‐reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study, European Journal of Heart Failure, 10.1016/j.ejheart.2007.11.003, 10:1, (63-69), Online publication date: 1-Jan-2008.

Miles E, Rees D, Banerjee T, Cazzola R, Lewis S, Wood R, Oates R, Tallant A, Cestaro B, Yaqoob P, Wahle K and Calder P (2008) Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations, Atherosclerosis, 10.1016/j.atherosclerosis.2006.11.002, 196:1, (298-305), Online publication date: 1-Jan-2008.

Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M and Kubota I (2008) Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure, American Heart Journal, 10.1016/j.ahj.2007.08.013, 155:1, (75-81), Online publication date: 1-Jan-2008.

Hartford M, Wiklund O, Mattsson Hultén L, Persson A, Karlsson T, Herlitz J and Caidahl K (2007) C‐reactive protein, interleukin‐6, secretory phospholipase A 2 group IIA and intercellular adhesion molecule‐1 in the prediction of late outcome events after acute coronary syndromes , Journal of Internal Medicine, 10.1111/j.1365-2796.2007.01862.x, 262:5, (526-536), Online publication date: 1-Nov-2007.

Turan R, Brehm M, Koestering M, Tobias Z, Bartsch T, Steiner S, Picard F, Ebner P, Schannwell C and Strauer B (2007) Factors influencing spontaneous mobilization of CD34 + and CD133 + progenitor cells after myocardial infarction , European Journal of Clinical Investigation, 10.1111/j.1365-2362.2007.01876.x, 37:11, (842-851), Online publication date: 1-Nov-2007.

Toblli J, Lombraña A, Duarte P and Di Gennaro F (2007) Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.07.029, 50:17, (1657-1665), Online publication date: 1-Oct-2007.

Sennerby U, Farahmand B, Ahlbom A, Ljunghall S and Michaëlsson K (2007) Cardiovascular diseases and future risk of hip fracture in women, Osteoporosis International, 10.1007/s00198-007-0386-0, 18:10, (1355-1362), Online publication date: 10-Sep-2007.

(2017) Chapter 1: Introduction, European Journal of Cardiovascular Prevention & Rehabilitation, 10.1097/01.hjr.0000277985.25720.16, 14:2_suppl, (S2-S113), Online publication date: 1-Sep-2007.

Monsuez J, Escaut L, Teicher E, Charniot J and Vittecoq D (2007) Cytokines in HIV-associated cardiomyopathy, International Journal of Cardiology, 10.1016/j.ijcard.2006.11.143, 120:2, (150-157), Online publication date: 1-Aug-2007.

Bursi F, Weston S, Killian J, Gabriel S, Jacobsen S and Roger V (2007) C-Reactive Protein and Heart Failure after Myocardial Infarction in the Community, The American Journal of Medicine, 10.1016/j.amjmed.2006.07.039, 120:7, (616-622), Online publication date: 1-Jul-2007.

Lavi S, Lavi R, McConnell J, Lerman L and Lerman A (2012) Lipoprotein-Associated Phospholipase A2, Molecular Diagnosis & Therapy, 10.1007/BF03256243, 11:4, (219-226), Online publication date: 1-Jul-2007.

JEFFS L, SKILTON F, NITSCHKE J, BANNISTER K and FAULL R (2007) Effect of pravastatin on markers of endothelial activation in dialysis patients, Nephrology, 10.1111/j.1440-1797.2007.00766.x, 12:3, (234-238), Online publication date: 1-Jun-2007.

Tanner H, Mohacsi P, Fuller-Bicer G, Rieben R, Meier B, Hess O and Hullin R (2007) Cytokine Activation and Disease Progression in Patients With Stable Moderate Chronic Heart Failure, The Journal of Heart and Lung Transplantation, 10.1016/j.healun.2007.01.033, 26:6, (622-629), Online publication date: 1-Jun-2007.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K and Fukunami M (2007) Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: A prospective randomized controlled study, American Heart Journal, 10.1016/j.ahj.2007.03.027, 153:6, (1055.e1-1055.e8), Online publication date: 1-Jun-2007.

Almoznino-Sarafian D, Berman S, Mor A, Shteinshnaider M, Gorelik O, Tzur I, Alon I, Modai D and Cohen N (2007) Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration?, European Journal of Nutrition, 10.1007/s00394-007-0655-x, 46:4, (230-237), Online publication date: 1-Jun-2007.

Malavazos A, Corsi M, Ermetici F, Coman C, Sardanelli F, Rossi A, Morricone L and Ambrosi B (2007) Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: Relationship with abdominal fat deposition, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2006.01.001, 17:4, (294-302), Online publication date: 1-May-2007.

Giamouzis G and Butler J (2007) Relationship Between Heart Failure and Lipids: The Paradigm Continues to Evolve, Journal of Cardiac Failure, 10.1016/j.cardfail.2007.03.009, 13:4, (254-258), Online publication date: 1-May-2007.

Ingelsson E, Lind L, Ärnlöv J and Sundström J (2007) Sleep disturbances independently predict heart failure in overweight middle‐aged men, European Journal of Heart Failure, 10.1016/j.ejheart.2006.05.012, 9:2, (184-190), Online publication date: 1-Feb-2007.

Okura H, Asawa K, Kubo T, Taguchi H, Toda I, Yoshiyama M, Yoshikawa J and Yoshida K (2007) Impact of Statin Therapy on Systemic Inflammation, Left Ventricular Systolic and Diastolic Function and Prognosis in Low Risk Ischemic Heart Disease Patients without History of Congestive Heart Failure, Internal Medicine, 10.2169/internalmedicine.46.0021, 46:17, (1337-1343), .

Power C, Miller S and Alpert P (2016) Promising New Causal Explanations for Obesity and Obesity-Related Diseases, Biological Research For Nursing, 10.1177/1099800406292674, 8:3, (223-233), Online publication date: 1-Jan-2007.

Fonarow G, Srikanthan P, Costanzo M, Cintron G and Lopatin M (2007) An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108927 patients in the Acute Decompensated Heart Failure National Registry, American Heart Journal, 10.1016/j.ahj.2006.09.007, 153:1, (74-81), Online publication date: 1-Jan-2007.

Gulliver G and Sweitzer N (2007) Risk Factor Management and Lifestyle Modification in Heart Failure Cardiovascular Therapeutics, 10.1016/B978-1-4160-3358-5.50019-X, (315-330), .

Ryan M (2007) Role of Cytokines and Inflammation in Hypertension Comprehensive Hypertension, 10.1016/B978-0-323-03961-1.50025-8, (229-239), .

Madjid M, Casscells S and Willerson J (2007) Biomarkers of Inflammation as Surrogate Markers in Detection of Vulnerable Plaques and Vulnerable Patients Cardiovascular Medicine, 10.1007/978-1-84628-715-2_28, (641-651), .

Foppa M, Duncan B, Arnett D, Benjamin E, Liebson P, Manolio T and Skelton T (2006) Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study, Cardiovascular Ultrasound, 10.1186/1476-7120-4-43, 4:1, Online publication date: 1-Dec-2006.

de Virginy D (2006) Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure, Heart Failure Reviews, 10.1007/s10741-006-0234-x, 11:4, (333-334), Online publication date: 1-Dec-2006.

Petersen J and Felker G (2007) Inflammatory Biomarkers in Heart Failure, Congestive Heart Failure, 10.1111/j.1527-5299.2006.05595.x, 12:6, (324-328), Online publication date: 1-Nov-2006.

Gil-Ortega I and Carlos Kaski J (2006) Miocardiopatía diabética, Medicina Clínica, 10.1157/13094003, 127:15, (584-594), Online publication date: 1-Oct-2006.

Boelen A, Wiersinga W and Koehrle J (2006) Contributions of cytokines to nonthyroidal illness, Current Opinion in Endocrinology and Diabetes, 10.1097/01.med.0000244227.21776.70, 13:5, (444-450), Online publication date: 1-Oct-2006.

Marfella R, Cacciapuoti F, Siniscalchi M, Sasso F, Marchese F, Cinone F, Musacchio E, Marfella M, Ruggiero L, Chiorazzo G, Liberti D, Chiorazzo G, Nicoletti G, Saron C, D’Andrea F, Ammendola C, Verza M and Coppola L (2006) Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus, Diabetic Medicine, 10.1111/j.1464-5491.2006.01886.x, 23:9, (974-981), Online publication date: 1-Sep-2006.

Terrell A, Crisostomo P, Wairiuko G, Wang M, Morrell E and Meldrum D (2006) JAK/STAT/SOCS SIGNALING CIRCUITS AND ASSOCIATED CYTOKINE-MEDIATED INFLAMMATION AND HYPERTROPHY IN THE HEART, Shock, 10.1097/01.shk.0000226341.32786.b9, 26:3, (226-234), Online publication date: 1-Sep-2006.

Kardys I, Knetsch A, Bleumink G, Deckers J, Hofman A, Stricker B and Witteman J (2006) C-reactive protein and risk of heart failure. The Rotterdam Study, American Heart Journal, 10.1016/j.ahj.2006.02.023, 152:3, (514-520), Online publication date: 1-Sep-2006.

Herbert A, Liu C, Karamohamed S, Liu J, Manning A, Fox C, Meigs J and Cupples L (2012) BMI Modifies Associations of IL‐6 Genotypes with Insulin Resistance: The Framingham Study, Obesity, 10.1038/oby.2006.165, 14:8, (1454-1461), Online publication date: 1-Aug-2006.

Kruger A, Stewart J, Sahityani R, O'Riordan E, Thompson C, Adler S, Garrick R, Vallance P and Goligorsky M (2006) Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: Correlation with cardiovascular risk, Kidney International, 10.1038/sj.ki.5001511, 70:1, (157-164), Online publication date: 1-Jul-2006.

Ng L, Pathik B, Loke I, Squire I and Davies J (2006) Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure, American Heart Journal, 10.1016/j.ahj.2005.09.020, 152:1, (94-101), Online publication date: 1-Jul-2006.

Faraj M, Messier L, Bastard J, Tardif A, Godbout A, Prud’homme D and Rabasa-Lhoret R (2006) Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women, Diabetologia, 10.1007/s00125-006-0259-7, 49:7, (1637-1646), Online publication date: 1-Jul-2006.

Rodgers G and Kopecky S (2006) The Future of Cardiovascular Biomarkers, The American Heart Hospital Journal, 10.1111/j.1541-9215.2006.05524.x, 4:3, (228-231), Online publication date: 1-Jun-2006.

Giles J, Post W, Blumenthal R and Bathon J (2006) Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis, Nature Clinical Practice Rheumatology, 10.1038/ncprheum0178, 2:6, (320-329), Online publication date: 1-Jun-2006.

De Martinis M, Franceschi C, Monti D and Ginaldi L (2006) Inflammation markers predicting frailty and mortality in the elderly, Experimental and Molecular Pathology, 10.1016/j.yexmp.2005.11.004, 80:3, (219-227), Online publication date: 1-Jun-2006.

Störk S, Feelders R, van den Beld A, Steyerberg E, Savelkoul H, Lamberts S, Grobbee D and Bots M (2006) Prediction of Mortality Risk in the Elderly, The American Journal of Medicine, 10.1016/j.amjmed.2005.10.062, 119:6, (519-525), Online publication date: 1-Jun-2006.

Schaap L, Pluijm S, Deeg D and Visser M (2006) Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength, The American Journal of Medicine, 10.1016/j.amjmed.2005.10.049, 119:6, (526.e9-526.e17), Online publication date: 1-Jun-2006.

MARCUCCI R, GORI A, GIANNOTTI F, BALDI M, VERDIANI V, DEL PACE S, NOZZOLI C and ABBATE R (2006) Markers of hypercoagulability and inflammation predict mortality in patients with heart failure, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2006.01916.x, 4:5, (1017-1022), Online publication date: 1-May-2006.

Shenoy M, Chapman C, Nawaz M and Sweitzer N (2007) Diagnosis and Management of Stage A Heart Failure, Congestive Heart Failure, 10.1111/j.1527-5299.2006.04621.x, 12:3, (146-152), Online publication date: 1-May-2006.

Kohut M, McCann D, Russell D, Konopka D, Cunnick J, Franke W, Castillo M, Reighard A and Vanderah E (2006) Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of β-blockers, BMI, and psychosocial factors in older adults, Brain, Behavior, and Immunity, 10.1016/j.bbi.2005.12.002, 20:3, (201-209), Online publication date: 1-May-2006.

Chan G, Fuse K, Sun M, Ayach B and Liu P (2006) Immune Modulatory Therapies in Heart Failure: Using Myocarditis to Gain Mechanistic Insights Heart Failure: Pharmacologic Management, 10.1002/9780470994740.ch12, (174-186), Online publication date: 25-Apr-2006.

Mozaffarian D, Katan M, Ascherio A, Stampfer M and Willett W (2006) Trans Fatty Acids and Cardiovascular Disease, New England Journal of Medicine, 10.1056/NEJMra054035, 354:15, (1601-1613), Online publication date: 13-Apr-2006.

Loucks E, Sullivan L, Hayes L, D'Agostino R, Larson M, Vasan R, Benjamin E and Berkman L (2006) Association of Educational Level with Inflammatory Markers in the Framingham Offspring Study, American Journal of Epidemiology, 10.1093/aje/kwj076, 163:7, (622-628), Online publication date: 1-Apr-2006.

White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin M, Racine N, He Y, Yao G, Rouleau J, Schiffrin E and Touyz R (2006) Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support, Clinical Science, 10.1042/CS20050317, 110:4, (483-489), Online publication date: 1-Apr-2006.

Loucks E, Berkman L, Gruenewald T and Seeman T (2006) Relation of Social Integration to Inflammatory Marker Concentrations in Men and Women 70 to 79 Years, The American Journal of Cardiology, 10.1016/j.amjcard.2005.10.043, 97:7, (1010-1016), Online publication date: 1-Apr-2006.

Lee D, Wang T and Ramachandran V (2006) Screening for ventricular remodeling, Current Heart Failure Reports, 10.1007/s11897-006-0025-7, 3:1, (5-13), Online publication date: 1-Apr-2006.

Poelaert J (2016) The Failing Heart Under Stress: Echocardiography is an Essential Monitoring Tool in the Intensive Care Unit, Seminars in Cardiothoracic and Vascular Anesthesia, 10.1177/108925320601000118, 10:1, (111-115), Online publication date: 1-Mar-2006.

Kelly K (2006) Acute Renal Failure: Much More Than a Kidney Disease, Seminars in Nephrology, 10.1016/j.semnephrol.2005.09.003, 26:2, (105-113), Online publication date: 1-Mar-2006.

Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H and Aronson D (2006) Early Inflammation and Risk of Long-Term Development of Heart Failure and Mortality in Survivors of Acute Myocardial Infarction, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.10.055, 47:5, (962-968), Online publication date: 1-Mar-2006.

Rutten F (2006) Kortademigheid: is het pulmonaal of cardiaal, of beide?, Bijblijven, 10.1007/BF03059921, 22:3, (114-120), Online publication date: 1-Mar-2006.

Zheng J, Chin A, Duignan I, Won K, Hong M and Edelberg J (2006) Growth factor-mediated reversal of senescent dysfunction of ischemia-induced cardioprotection, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00470.2005, 290:2, (H525-H530), Online publication date: 1-Feb-2006.

Shah S, Marcus G, Gerber I, Mckeown B, Vessey J, Jordan M, Huddleston M, Foster E, Chatterjee K and Michaels A (2006) High-Sensitivity C-Reactive Protein and Parameters of Left Ventricular Dysfunction, Journal of Cardiac Failure, 10.1016/j.cardfail.2005.08.003, 12:1, (61-65), Online publication date: 1-Feb-2006.

Schwartzenberg S, Ben-Shoshan J, Keren G and George J (2014) The role of erythropoietin in myocardial protection: potential mechanisms and applications, Expert Review of Cardiovascular Therapy, 10.1586/14779072.4.1.41, 4:1, (41-50), Online publication date: 1-Jan-2006.

TETTA C, DAVID S, MARCELLI D, COGLIATI P, FORMICA M, INGUAGGIATO P and PANICHI V (2006) Clinical effects of online dialysate and infusion fluids, Hemodialysis International, 10.1111/j.1542-4758.2006.01194.x, 10:s1, Online publication date: 1-Jan-2006.

Thethi T, Bratcher C and Fonseca V (2006) Metabolic Syndrome and Heart Failure, Heart Failure Clinics, 10.1016/j.hfc.2005.11.006, 2:1, (1-11), Online publication date: 1-Jan-2006.

Conen D, Zeller A, Pfisterer M and Martina B (2006) Usefulness of B-Type Natriuretic Peptide and C-Reactive Protein in Predicting the Presence or Absence of Left Ventricular Hypertrophy in Patients With Systemic Hypertension, The American Journal of Cardiology, 10.1016/j.amjcard.2005.08.028, 97:2, (249-252), Online publication date: 1-Jan-2006.

Barasch E, Gottdiener J, Marino Larsen E, Chaves P, Newman A and Manolio T (2006) Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS), American Heart Journal, 10.1016/j.ahj.2005.03.052, 151:1, (39-47), Online publication date: 1-Jan-2006.

Thomas D Cytokines and Disability in Older Adults Cachexia and Wasting: A Modern Approach, 10.1007/978-88-470-0552-5_39, (397-404)

Bozkurt B (2006) Biomarkers of Inflammation Cardiovascular Biomarkers, 10.1007/978-1-59745-051-5_19, (295-318), .

Bassuk S and Ridker P (2006) C-Reactive Protein as a Tool for Risk Assessment in Primary Prevention Cardiovascular Biomarkers, 10.1007/978-1-59745-051-5_16, (237-260), .

Scoote M, Purcell I and Poole-Wilson P Pathophysiology of Heart Failure Essential Cardiology, 10.1007/978-1-59259-918-9_19, (347-369)

Nicola P, Crowson C, Maradit‐Kremers H, Ballman K, Roger V, Jacobsen S and Gabriel S (2005) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis, Arthritis & Rheumatism, 10.1002/art.21560, 54:1, (60-67), Online publication date: 1-Jan-2006.

Friedman E, Hayney M, Love G, Urry H, Rosenkranz M, Davidson R, Singer B and Ryff C (2005) Social relationships, sleep quality, and interleukin-6 in aging women, Proceedings of the National Academy of Sciences, 10.1073/pnas.0509281102, 102:51, (18757-18762), Online publication date: 20-Dec-2005.

Greiser K, Kluttig A, Schumann B, Kors J, Swenne C, Kuss O, Werdan K and Haerting J (2005) Cardiovascular disease, risk factors and heart rate variability in the elderly general population: Design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study, BMC Cardiovascular Disorders, 10.1186/1471-2261-5-33, 5:1, Online publication date: 1-Dec-2005.

Ingelsson E, Ärnlöv J, Sundström J, Zethelius B, Vessby B and Lind L (2005) Novel Metabolic Risk Factors for Heart Failure, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.07.059, 46:11, (2054-2060), Online publication date: 1-Dec-2005.

Kip K, Marroquin O, Shaw L, Arant C, Wessel T, Olson M, Johnson B, Mulukutla S, Sopko G, Merz C and Reis S (2005) Global inflammation predicts cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study, American Heart Journal, 10.1016/j.ahj.2005.02.002, 150:5, (900-906), Online publication date: 1-Nov-2005.

Il'yasova D, Colbert L, Harris T, Newman A, Bauer D, Satterfield S and Kritchevsky S (2005) Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort, Cancer Epidemiology, Biomarkers & Prevention, 10.1158/1055-9965.EPI-05-0316, 14:10, (2413-2418), Online publication date: 1-Oct-2005.

Lehtimäki T, Ojala P, Rontu R, Goebeler S, Karhunen P, Jylhä M, Mattila K, Metso S, Jokela H, Nikkilä M, Wuolijoki E, Hervonen A and Hurme M (2005) Interleukin‐6 Modulates Plasma Cholesterol and C‐Reactive Protein Concentrations in Nonagenarians, Journal of the American Geriatrics Society, 10.1111/j.1532-5415.2005.53484.x, 53:9, (1552-1558), Online publication date: 1-Sep-2005.

Friedman A, Hunsicker L, Selhub J and Bostom A (2005) C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy, Kidney International, 10.1111/j.1523-1755.2005.00456.x, 68:2, (773-778), Online publication date: 1-Aug-2005.

Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I and Hiramori K (2005) C‐reactive protein co‐expresses with tumor necrosis factor‐α in the myocardium in human dilated cardiomyopathy, European Journal of Heart Failure, 10.1016/j.ejheart.2004.10.018, 7:5, (748-754), Online publication date: 1-Aug-2005.

Diamant M, Lamb H, Smit J, de Roos A and Heine R (2005) Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation, Diabetologia, 10.1007/s00125-005-1821-4, 48:8, (1669-1670), Online publication date: 1-Aug-2005.

Cugno M, Agostoni P, Mari D, Meroni P, Gregorini L, Bussotti M, Anguissola G, Donatelli F and Nussberger J (2005) Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin‐converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation, British Journal of Haematology, 10.1111/j.1365-2141.2005.05569.x, 130:1, (113-120), Online publication date: 1-Jul-2005.

Ingelsson E, Årnlöv J, Sundström J and Lind L (2005) Inflammation, as Measured by the Erythrocyte Sedimentation Rate, Is an Independent Predictor for the Development of Heart Failure, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.02.066, 45:11, (1802-1806), Online publication date: 1-Jun-2005.

Wollner D (2005) Frailty in the older adult, NPG Neurologie - Psychiatrie - Gériatrie, 10.1016/S1627-4830(05)82578-4, 5:27, (39-41), Online publication date: 1-Jun-2005.

Devillier P (2005) Corticothérapie inhalée : un traitement à impacts multiples, Revue de Pneumologie Clinique, 10.1016/S0761-8417(05)84883-7, 61, (30-33), Online publication date: 1-Jun-2005.

King D (2005) Dietary fiber, inflammation, and cardiovascular disease, Molecular Nutrition & Food Research, 10.1002/mnfr.200400112, 49:6, (594-600), Online publication date: 1-Jun-2005.

Berg A and Scherer P (2005) Adipose Tissue, Inflammation, and Cardiovascular Disease, Circulation Research, 96:9, (939-949), Online publication date: 13-May-2005.

Clark W, Paganini E, Weinstein D, Bartlett R, Sheinfeld G and Ronco C (2018) Extracorporeal Ultrafiltration for Acute Exacerbations of Chronic Heart Failure: Report from the Acute Dialysis Quality Initiative, The International Journal of Artificial Organs, 10.1177/039139880502800507, 28:5, (466-476), Online publication date: 1-May-2005.

Lee D and Vasan R (2005) Novel markers for heart failure diagnosis and prognosis, Current Opinion in Cardiology, 10.1097/01.hco.0000161832.04952.6a, 20:3, (201-210), Online publication date: 1-May-2005.

Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, Cicchitelli G, Olivares A, Parrinello G, Percoco G, Guardigli G, Mele D, Pirani R and Ferrari R (2005) Tumor Necrosis Factor-α Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial Infarction, Circulation, 111:7, (863-870), Online publication date: 22-Feb-2005.

Jánoskuti L, Förhécz Z, Hosszúfalusi N, Kleiber M, Walentin S, Bálint O, Duba J, Rugonfalvi‐Kiss S, Romics L, Karádi I, Füst G and Prohászka Z (2005) High levels of C‐reactive protein with low total cholesterol concentrations additively predict all‐cause mortality in patients with coronary artery disease, European Journal of Clinical Investigation, 10.1111/j.1365-2362.2005.01465.x, 35:2, (104-111), Online publication date: 1-Feb-2005.

Nicola P, Maradit‐Kremers H, Roger V, Jacobsen S, Crowson C, Ballman K and Gabriel S (2005) The risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years, Arthritis & Rheumatism, 10.1002/art.20855, 52:2, (412-420), Online publication date: 1-Feb-2005.

Hazzard W (2005) Frailty Cardiovascular Disease in the Elderly, 10.1385/1-59259-941-9:051, (51-77), .

Campbell D, Woodward M, Chalmers J, Colman S, Jenkins A, Kemp B, Neal B, Patel A and MacMahon S (2004) Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease, Hypertension, 45:1, (69-74), Online publication date: 1-Jan-2005.

LAMPARTER S and GRIMM W (2005) Predictive Value of High‐Sensitivity C‐Reactive Protein in Patients with Idiopathic Dilated Cardiomyopathy, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.2005.00034.x, 28:s1, Online publication date: 1-Jan-2005.

Fedak P, Verma S, Weisel R and Li R (2005) Cardiac remodeling and failure, Cardiovascular Pathology, 10.1016/j.carpath.2004.12.002, 14:1, (1-11), Online publication date: 1-Jan-2005.

Chirinos J, Zambrano J, Chakko S, Schob A, Veerani A, Perez G and Mendez A (2005) Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy, The American Journal of Cardiology, 10.1016/j.amjcard.2004.08.065, 95:1, (88-90), Online publication date: 1-Jan-2005.

Sawyer D and Colucci W (2005) Molecular and Cellular Events in Myocardial Hypertrophy and Failure Atlas of HEART FAILURE, 10.1007/978-1-4757-4558-0_4, (61-81), .

Köprülü D, Yesildag O, Meric M, Demircan S, Aygul E, Kaya M and Balci B (2011) The effect of medical treatment on the level of C-Reactive protein and leukocyte count in patients with congestiveheart failure, International Journal of Angiology, 10.1007/s00547-004-1051-5, 13:04, (168-172)

Marian A and Nambi V (2014) Biomarkers of cardiac disease, Expert Review of Molecular Diagnostics, 10.1586/14737159.4.6.805, 4:6, (805-820), Online publication date: 1-Nov-2004.

Rma v, AA V, HWM P, WH v and DJ v (2004) New Pharmacological Strategies in Chronic Heart Failure, Cardiovascular Drugs and Therapy, 10.1007/s10557-004-6227-x, 18:6, (491-501), Online publication date: 1-Nov-2004.

Kim J, Washio T, Yamagishi M, Yasumura Y, Nakatani S, Hashimura K, Hanatani A, Komamura K, Miyatake K, Kitamura S, Tomoike H and Kitakaze M (2004) A Novel Data Mining Approach to the Identification of Effective Drugs or Combinations for Targeted Endpoints?Application to Chronic Heart Failure as a New Form of Evidence-based Medicine, Cardiovascular Drugs and Therapy, 10.1007/s10557-004-6226-y, 18:6, (483-489), Online publication date: 1-Nov-2004.

King D, Mainous A and Taylor M (2004) Clinical Use of C-reactive Protein for Cardiovascular Disease, Southern Medical Journal, 10.1097/01.SMJ.0000140863.20371.FB, 97:10, (985-988), Online publication date: 1-Oct-2004.

Kenchaiah S, Narula J and Vasan R (2004) Risk factors for heart failure, Medical Clinics of North America, 10.1016/j.mcna.2004.04.016, 88:5, (1145-1172), Online publication date: 1-Sep-2004.

Kenchaiah S, Gaziano J and Vasan R (2004) Impact of obesity on the risk of heart failure and survival after the onset of heart failure, Medical Clinics of North America, 10.1016/j.mcna.2004.04.011, 88:5, (1273-1294), Online publication date: 1-Sep-2004.

Bassuk S, Rifai N and Ridker P (2004) High-sensitivity C-reactive protein, Current Problems in Cardiology, 10.1016/j.cpcardiol.2004.03.004, 29:8, (439-493), Online publication date: 1-Aug-2004.

Nian M, Lee P, Khaper N and Liu P (2004) Inflammatory Cytokines and Postmyocardial Infarction Remodeling, Circulation Research, 94:12, (1543-1553), Online publication date: 25-Jun-2004.

Panichi V, Maggiore U, Taccola D, Migliori M, Rizza G, Consani C, Bertini A, Sposini S, Perez-Garcia R, Rindi P, Palla R and Tetta C (2004) Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients, Nephrology Dialysis Transplantation, 10.1093/ndt/gfh052, 19:5, (1154-1160), Online publication date: 1-May-2004.

Gibbons G (2007) Physiology, Genetics, and Cardiovascular Disease: Focus on African Americans, The Journal of Clinical Hypertension, 10.1111/j.1524-6175.2004.03562.x, 6:s4, (11-18), Online publication date: 1-Apr-2004.

Talvani A, Rocha M, Barcelos L, Gomes Y, Ribeiro A and Teixeira M (2004) Elevated Concentrations of CCL2 and Tumor Necrosis Factor–α in Chagasic Cardiomyopathy, Clinical Infectious Diseases, 10.1086/381892, 38:7, (943-950), Online publication date: 1-Apr-2004.

Castaneda C, Gordon P, Parker R, Uhlin K, Roubenoff R and Levey A (2004) Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease, American Journal of Kidney Diseases, 10.1053/j.ajkd.2003.12.025, 43:4, (607-616), Online publication date: 1-Apr-2004.

Matsumori A (2004) Anti-inflammatory therapy for heart failure, Current Opinion in Pharmacology, 10.1016/j.coph.2003.11.003, 4:2, (171-176), Online publication date: 1-Apr-2004.

Henry R, Kamp O, Kostense P, Spijkerman A, Dekker J, van Eijck R, Nijpels G, Heine R, Bouter L and Stehouwer C (2004) Left Ventricular Mass Increases With Deteriorating Glucose Tolerance, Especially in Women: Independence of Increased Arterial Stiffness or Decreased Flow-Mediated Dilation, Diabetes Care, 10.2337/diacare.27.2.522, 27:2, (522-529), Online publication date: 1-Feb-2004.

Feingold K, Kim M, Shigenaga J, Moser A and Grunfeld C (2004) Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response, American Journal of Physiology-Endocrinology and Metabolism, 10.1152/ajpendo.00205.2003, 286:2, (E201-E207), Online publication date: 1-Feb-2004.

Rodríguez-Artalejo F, Banegas Banegas J and Guallar-Castillón P (2004) Epidemiology of Heart Failure, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(06)60106-0, 57:2, (163-170), Online publication date: 1-Feb-2004.

Marfella R, Esposito K, Siniscalchi M, Cacciapuoti F, Giugliano F, Labriola D, Ciotola M, Di Palo C, Misso L and Giugliano D (2004) Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women, Diabetes Care, 10.2337/diacare.27.1.47, 27:1, (47-52), Online publication date: 1-Jan-2004.

Rodríguez-Artalejo F, Banegas Banegas J and Guallar-Castillón P (2004) Epidemiología de la insuficiencia cardíaca, Revista Española de Cardiología, 10.1016/S0300-8932(04)77080-3, 57:2, (163-170), Online publication date: 1-Jan-2004.

Baker L, Meldrum K, Wang M, Sankula R, Vanam R, Raiesdana A, Tsai B, Hile K, Brown J and Meldrum D (2003) The role of estrogen in cardiovascular disease, Journal of Surgical Research, 10.1016/S0022-4804(03)00215-4, 115:2, (325-344), Online publication date: 1-Dec-2003.

Cesari M, Penninx B, Newman A, Kritchevsky S, Nicklas B, Sutton-Tyrrell K, Rubin S, Ding J, Simonsick E, Harris T and Pahor M (2003) Inflammatory Markers and Onset of Cardiovascular Events, Circulation, 108:19, (2317-2322), Online publication date: 11-Nov-2003.

Thomas D (2003) The Relationship Between Functional Status and Inflammatory Disease in Older Adults, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 10.1093/gerona/58.11.M995, 58:11, (M995-M998), Online publication date: 1-Nov-2003.

Ware L, Fang X and Matthay M (2003) Protein C and thrombomodulin in human acute lung injury, American Journal of Physiology-Lung Cellular and Molecular Physiology, 10.1152/ajplung.00442.2002, 285:3, (L514-L521), Online publication date: 1-Sep-2003.

Abrams J (2003) C-reactive protein, inflammation, and coronary risk: an update, Cardiology Clinics, 10.1016/S0733-8651(03)00082-1, 21:3, (327-331), Online publication date: 1-Aug-2003.

Murray D and Freeman G (2003) Proinflammatory Cytokines, Circulation, 107:11, (1460-1462), Online publication date: 25-Mar-2003.

March 25, 2003
Vol 107, Issue 11

Article Information

Metrics

https://doi.org/10.1161/01.CIR.0000057810.48709.F6

PMID: 12654604

Originally publishedMarch 10, 2003

Keywords

PDF download

OpenAthens/Shibboleth »

Jump to

Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

You are viewing the most recent version of this article. Previous versions: